id	sid	tid	token	lemma	pos
clinmedi-42	1	1	clinical	clinical	ADJ
clinmedi-42	1	2	medicine	medicine	NOUN
clinmedi-42	1	3	insight	insight	NOUN
clinmedi-42	1	4	80	80	NUM
clinmedi-42	1	5	-	-	PUNCT
clinmedi-42	1	6	6pages	6pages	NUM
clinmedi-42	1	7	:	:	PUNCT
clinmedi-42	1	8	0	0	NUM
clinmedi-42	1	9	2020	2020	NUM
clinmedi-42	1	10	-	-	SYM
clinmedi-42	1	11	09	09	NUM
clinmedi-42	1	12	-	-	PUNCT
clinmedi-42	1	13	2020	2020	NUM
clinmedi-42	1	14	|	|	ADV
clinmedi-42	1	15	published	publish	VERB
clinmedi-42	1	16	:	:	PUNCT
clinmedi-42	1	17	19	19	NUM
clinmedi-42	1	18	-	-	SYM
clinmedi-42	1	19	90	90	NUM
clinmedi-42	1	20	-	-	PUNCT
clinmedi-42	1	21	52020	52020	NUM
clinmedi-42	1	22	|	|	ADV
clinmedi-42	1	23	accepted	accept	VERB
clinmedi-42	1	24	:	:	PUNCT
clinmedi-42	1	25	1	1	NUM
clinmedi-42	1	26	-	-	SYM
clinmedi-42	1	27	80	80	NUM
clinmedi-42	1	28	-	-	PUNCT
clinmedi-42	1	29	01received	01receive	VERB
clinmedi-42	1	30	:	:	PUNCT
clinmedi-42	1	31	clinical	clinical	ADJ
clinmedi-42	1	32	medicine	medicine	NOUN
clinmedi-42	1	33	insights	insight	NOUN
clinmedi-42	1	34	page	page	VERB
clinmedi-42	1	35	6	6	NUM
clinmedi-42	1	36	rituximab	rituximab	NOUN
clinmedi-42	1	37	treatment	treatment	NOUN
clinmedi-42	1	38	for	for	ADP
clinmedi-42	1	39	chronic	chronic	ADJ
clinmedi-42	1	40	idiopathic	idiopathic	ADJ
clinmedi-42	1	41	urticaria	urticaria	NOUN
clinmedi-42	1	42	with	with	ADP
clinmedi-42	1	43	recurrent	recurrent	ADJ
clinmedi-42	1	44	angioedema	angioedema	NOUN
clinmedi-42	1	45	dr	dr	PROPN
clinmedi-42	1	46	.	.	PROPN
clinmedi-42	1	47	vikola	vikola	PROPN
clinmedi-42	1	48	yigovski	yigovski	PROPN
clinmedi-42	1	49	dept	dept	NOUN
clinmedi-42	1	50	.	.	PROPN
clinmedi-42	1	51	of	of	ADP
clinmedi-42	1	52	medicine	medicine	NOUN
clinmedi-42	1	53	,	,	PUNCT
clinmedi-42	1	54	faculty	faculty	NOUN
clinmedi-42	1	55	of	of	ADP
clinmedi-42	1	56	medicine	medicine	NOUN
clinmedi-42	1	57	,	,	PUNCT
clinmedi-42	1	58	china	china	PROPN
clinmedi-42	1	59	abstract	abstract	NOUN
clinmedi-42	1	60	:	:	PUNCT
clinmedi-42	1	61	we	we	PRON
clinmedi-42	1	62	report	report	VERB
clinmedi-42	1	63	on	on	ADP
clinmedi-42	1	64	4	4	NUM
clinmedi-42	1	65	patients	patient	NOUN
clinmedi-42	1	66	with	with	ADP
clinmedi-42	1	67	severe	severe	ADJ
clinmedi-42	1	68	chronic	chronic	ADJ
clinmedi-42	1	69	urticaria	urticaria	NOUN
clinmedi-42	1	70	and	and	CCONJ
clinmedi-42	1	71	idiopathic	idiopathic	ADJ
clinmedi-42	1	72	recurrence	recurrence	NOUN
clinmedi-42	1	73	with	with	ADP
clinmedi-42	1	74	angioedema	angioedema	NOUN
clinmedi-42	1	75	attacks	attack	NOUN
clinmedi-42	1	76	.	.	PUNCT
clinmedi-42	2	1	initially	initially	ADV
clinmedi-42	2	2	,	,	PUNCT
clinmedi-42	2	3	they	they	PRON
clinmedi-42	2	4	initially	initially	ADV
clinmedi-42	2	5	respond	respond	VERB
clinmedi-42	2	6	to	to	ADP
clinmedi-42	2	7	high	high	ADJ
clinmedi-42	2	8	-	-	PUNCT
clinmedi-42	2	9	dose	dose	NOUN
clinmedi-42	2	10	corticosteroids	corticosteroid	NOUN
clinmedi-42	2	11	but	but	CCONJ
clinmedi-42	2	12	still	still	ADV
clinmedi-42	2	13	recur	recur	VERB
clinmedi-42	2	14	on	on	ADP
clinmedi-42	2	15	a	a	DET
clinmedi-42	2	16	high	high	ADJ
clinmedi-42	2	17	-	-	PUNCT
clinmedi-42	2	18	protection	protection	NOUN
clinmedi-42	2	19	dose	dose	NOUN
clinmedi-42	2	20	.	.	PUNCT
clinmedi-42	3	1	next	next	ADV
clinmedi-42	3	2	,	,	PUNCT
clinmedi-42	3	3	test	test	VERB
clinmedi-42	3	4	the	the	DET
clinmedi-42	3	5	use	use	NOUN
clinmedi-42	3	6	of	of	ADP
clinmedi-42	3	7	steroid	steroid	NOUN
clinmedi-42	3	8	-	-	PUNCT
clinmedi-42	3	9	sparking	spark	VERB
clinmedi-42	3	10	drugs	drug	NOUN
clinmedi-42	3	11	i.e	i.e	X
clinmedi-42	3	12	..	..	PUNCT
clinmedi-42	3	13	internal	internal	ADJ
clinmedi-42	3	14	immunoglobulin	immunoglobulin	NOUN
clinmedi-42	3	15	then	then	ADV
clinmedi-42	3	16	mycophenolate	mycophenolate	VERB
clinmedi-42	3	17	mofetil	mofetil	PROPN
clinmedi-42	3	18	with	with	ADP
clinmedi-42	3	19	hydroxychloroquine	hydroxychloroquine	PROPN
clinmedi-42	3	20	and	and	CCONJ
clinmedi-42	3	21	tacrolimus	tacrolimus	PROPN
clinmedi-42	3	22	could	could	AUX
clinmedi-42	3	23	not	not	PART
clinmedi-42	3	24	sustain	sustain	VERB
clinmedi-42	3	25	a	a	DET
clinmedi-42	3	26	quench	quench	NOUN
clinmedi-42	3	27	.	.	PUNCT
clinmedi-42	4	1	therefore	therefore	ADV
clinmedi-42	4	2	,	,	PUNCT
clinmedi-42	4	3	rituximab	rituximab	NOUN
clinmedi-42	4	4	was	be	AUX
clinmedi-42	4	5	given	give	VERB
clinmedi-42	4	6	.	.	PUNCT
clinmedi-42	5	1	one	one	NUM
clinmedi-42	5	2	month	month	NOUN
clinmedi-42	5	3	after	after	ADP
clinmedi-42	5	4	rituximab	rituximab	NOUN
clinmedi-42	5	5	infections	infection	NOUN
clinmedi-42	5	6	,	,	PUNCT
clinmedi-42	5	7	the	the	DET
clinmedi-42	5	8	prednisone	prednisone	PROPN
clinmedi-42	5	9	dose	dose	NOUN
clinmedi-42	5	10	was	be	AUX
clinmedi-42	5	11	successfully	successfully	ADV
clinmedi-42	5	12	discontinued	discontinue	VERB
clinmedi-42	5	13	and	and	CCONJ
clinmedi-42	5	14	discontinued	discontinue	VERB
clinmedi-42	5	15	.	.	PUNCT
clinmedi-42	6	1	subsequently	subsequently	ADV
clinmedi-42	6	2	,	,	PUNCT
clinmedi-42	6	3	all	all	DET
clinmedi-42	6	4	patients	patient	NOUN
clinmedi-42	6	5	remained	remain	VERB
clinmedi-42	6	6	in	in	ADP
clinmedi-42	6	7	complete	complete	ADJ
clinmedi-42	6	8	rest	rest	NOUN
clinmedi-42	6	9	for	for	ADP
clinmedi-42	6	10	10	10	NUM
clinmedi-42	6	11	-	-	SYM
clinmedi-42	6	12	18	18	NUM
clinmedi-42	6	13	months	month	NOUN
clinmedi-42	6	14	.	.	PUNCT
clinmedi-42	7	1	key	key	ADJ
clinmedi-42	7	2	words	word	NOUN
clinmedi-42	7	3	:	:	PUNCT
clinmedi-42	7	4	angioedema	angioedema	ADV
clinmedi-42	7	5	,	,	PUNCT
clinmedi-42	7	6	prednisone	prednisone	NOUN
clinmedi-42	7	7	,	,	PUNCT
clinmedi-42	7	8	rituximab	rituximab	NOUN
clinmedi-42	7	9	,	,	PUNCT
clinmedi-42	7	10	urticaria	urticaria	PROPN
clinmedi-42	7	11	.	.	PUNCT
clinmedi-42	8	1	introduction	introduction	NOUN
clinmedi-42	8	2	:	:	PUNCT
clinmedi-42	8	3	urticaria	urticaria	PROPN
clinmedi-42	8	4	is	be	AUX
clinmedi-42	8	5	a	a	DET
clinmedi-42	8	6	common	common	ADJ
clinmedi-42	8	7	dermatological	dermatological	ADJ
clinmedi-42	8	8	condition	condition	NOUN
clinmedi-42	8	9	which	which	PRON
clinmedi-42	8	10	typically	typically	ADV
clinmedi-42	8	11	presents	present	VERB
clinmedi-42	8	12	with	with	ADP
clinmedi-42	8	13	intensively	intensively	ADV
clinmedi-42	8	14	pruritic	pruritic	ADJ
clinmedi-42	8	15	,	,	PUNCT
clinmedi-42	8	16	wellcircumscribed	wellcircumscribe	VERB
clinmedi-42	8	17	,	,	PUNCT
clinmedi-42	8	18	raised	raise	VERB
clinmedi-42	8	19	wheels	wheel	NOUN
clinmedi-42	8	20	ranging	range	VERB
clinmedi-42	8	21	from	from	ADP
clinmedi-42	8	22	several	several	ADJ
clinmedi-42	8	23	millimeters	millimeter	NOUN
clinmedi-42	8	24	to	to	ADP
clinmedi-42	8	25	several	several	ADJ
clinmedi-42	8	26	centimeters	centimeter	NOUN
clinmedi-42	8	27	or	or	CCONJ
clinmedi-42	8	28	larger	large	ADJ
clinmedi-42	8	29	size	size	NOUN
clinmedi-42	8	30	.	.	PUNCT
clinmedi-42	9	1	urticaria	urticaria	PROPN
clinmedi-42	9	2	can	can	AUX
clinmedi-42	9	3	occur	occur	VERB
clinmedi-42	9	4	with	with	ADP
clinmedi-42	9	5	angioedema	angioedema	NOUN
clinmedi-42	9	6	,	,	PUNCT
clinmedi-42	9	7	which	which	PRON
clinmedi-42	9	8	is	be	AUX
clinmedi-42	9	9	localized	localize	VERB
clinmedi-42	9	10	non	non	ADJ
clinmedi-42	9	11	-	-	ADJ
clinmedi-42	9	12	pitting	pitting	ADJ
clinmedi-42	9	13	edema	edema	NOUN
clinmedi-42	9	14	of	of	ADP
clinmedi-42	9	15	the	the	DET
clinmedi-42	9	16	subcutaneous	subcutaneous	ADJ
clinmedi-42	9	17	tissue	tissue	NOUN
clinmedi-42	9	18	that	that	PRON
clinmedi-42	9	19	can	can	AUX
clinmedi-42	9	20	be	be	AUX
clinmedi-42	9	21	painful	painful	ADJ
clinmedi-42	9	22	and	and	CCONJ
clinmedi-42	9	23	obstructs	obstruct	VERB
clinmedi-42	9	24	the	the	DET
clinmedi-42	9	25	air	air	NOUN
clinmedi-42	9	26	way	way	NOUN
clinmedi-42	9	27	.	.	PUNCT
clinmedi-42	10	1	chronic	chronic	ADJ
clinmedi-42	10	2	urticaria	urticaria	NOUN
clinmedi-42	10	3	(	(	PUNCT
clinmedi-42	10	4	cu	cu	PROPN
clinmedi-42	10	5	)	)	PUNCT
clinmedi-42	10	6	is	be	AUX
clinmedi-42	10	7	defined	define	VERB
clinmedi-42	10	8	as	as	ADP
clinmedi-42	10	9	urticaria	urticaria	NOUN
clinmedi-42	10	10	persisting	persist	VERB
clinmedi-42	10	11	almost	almost	ADV
clinmedi-42	10	12	daily	daily	ADV
clinmedi-42	10	13	for	for	ADP
clinmedi-42	10	14	more	more	ADJ
clinmedi-42	10	15	than	than	ADP
clinmedi-42	10	16	six	six	NUM
clinmedi-42	10	17	weeks	week	NOUN
clinmedi-42	11	1	[	[	X
clinmedi-42	11	2	1	1	NUM
clinmedi-42	11	3	]	]	PUNCT
clinmedi-42	11	4	.	.	PUNCT
clinmedi-42	12	1	it	it	PRON
clinmedi-42	12	2	generally	generally	ADV
clinmedi-42	12	3	lasts	last	VERB
clinmedi-42	12	4	1	1	NUM
clinmedi-42	12	5	to	to	PART
clinmedi-42	12	6	5	5	NUM
clinmedi-42	12	7	years	year	NOUN
clinmedi-42	12	8	,	,	PUNCT
clinmedi-42	12	9	but	but	CCONJ
clinmedi-42	12	10	can	can	AUX
clinmedi-42	12	11	have	have	VERB
clinmedi-42	12	12	a	a	DET
clinmedi-42	12	13	prolonged	prolonged	ADJ
clinmedi-42	12	14	course	course	NOUN
clinmedi-42	12	15	beyond	beyond	ADP
clinmedi-42	12	16	5	5	NUM
clinmedi-42	12	17	years	year	NOUN
clinmedi-42	12	18	in	in	ADP
clinmedi-42	12	19	roughly	roughly	ADV
clinmedi-42	12	20	14	14	NUM
clinmedi-42	12	21	%	%	NOUN
clinmedi-42	12	22	of	of	ADP
clinmedi-42	12	23	patients	patient	NOUN
clinmedi-42	12	24	[	[	X
clinmedi-42	12	25	2	2	NUM
clinmedi-42	12	26	]	]	PUNCT
clinmedi-42	12	27	.	.	PUNCT
clinmedi-42	13	1	the	the	DET
clinmedi-42	13	2	latter	latter	ADJ
clinmedi-42	13	3	is	be	AUX
clinmedi-42	13	4	considered	consider	VERB
clinmedi-42	13	5	a	a	DET
clinmedi-42	13	6	major	major	ADJ
clinmedi-42	13	7	health	health	NOUN
clinmedi-42	13	8	burden	burden	NOUN
clinmedi-42	13	9	since	since	SCONJ
clinmedi-42	13	10	the	the	DET
clinmedi-42	13	11	persistent	persistent	ADJ
clinmedi-42	13	12	pruritis	pruritis	NOUN
clinmedi-42	13	13	impairs	impair	VERB
clinmedi-42	13	14	daily	daily	ADJ
clinmedi-42	13	15	functions	function	NOUN
clinmedi-42	13	16	,	,	PUNCT
clinmedi-42	13	17	disturbs	disturbs	AUX
clinmedi-42	13	18	sleep	sleep	VERB
clinmedi-42	13	19	and	and	CCONJ
clinmedi-42	13	20	hence	hence	ADV
clinmedi-42	13	21	the	the	DET
clinmedi-42	13	22	quality	quality	NOUN
clinmedi-42	13	23	of	of	ADP
clinmedi-42	13	24	life	life	NOUN
clinmedi-42	13	25	[	[	X
clinmedi-42	13	26	3	3	NUM
clinmedi-42	13	27	]	]	PUNCT
clinmedi-42	13	28	.	.	PUNCT
clinmedi-42	14	1	in	in	ADP
clinmedi-42	14	2	general	general	ADJ
clinmedi-42	14	3	population	population	NOUN
clinmedi-42	14	4	the	the	DET
clinmedi-42	14	5	prevalence	prevalence	NOUN
clinmedi-42	14	6	of	of	ADP
clinmedi-42	14	7	cu	cu	PROPN
clinmedi-42	14	8	is	be	AUX
clinmedi-42	14	9	0.5	0.5	NUM
clinmedi-42	14	10	-	-	SYM
clinmedi-42	14	11	5	5	NUM
clinmedi-42	14	12	%	%	NOUN
clinmedi-42	14	13	[	[	X
clinmedi-42	14	14	4	4	NUM
clinmedi-42	14	15	]	]	PUNCT
clinmedi-42	14	16	.	.	PUNCT
clinmedi-42	15	1	according	accord	VERB
clinmedi-42	15	2	to	to	ADP
clinmedi-42	15	3	the	the	DET
clinmedi-42	15	4	grade	grade	NOUN
clinmedi-42	15	5	system	system	NOUN
clinmedi-42	15	6	,	,	PUNCT
clinmedi-42	15	7	the	the	DET
clinmedi-42	15	8	mainstay	mainstay	NOUN
clinmedi-42	15	9	of	of	ADP
clinmedi-42	15	10	treatment	treatment	NOUN
clinmedi-42	15	11	of	of	ADP
clinmedi-42	15	12	urticaria	urticaria	NOUN
clinmedi-42	15	13	is	be	AUX
clinmedi-42	15	14	avoidance	avoidance	NOUN
clinmedi-42	15	15	of	of	ADP
clinmedi-42	15	16	identified	identify	VERB
clinmedi-42	15	17	triggers	trigger	NOUN
clinmedi-42	15	18	,	,	PUNCT
clinmedi-42	15	19	second	second	ADJ
clinmedi-42	15	20	-	-	PUNCT
clinmedi-42	15	21	generation	generation	NOUN
clinmedi-42	15	22	h1	h1	NOUN
clinmedi-42	15	23	antihistamines	antihistamine	NOUN
clinmedi-42	15	24	,	,	PUNCT
clinmedi-42	15	25	leukotriene	leukotriene	NOUN
clinmedi-42	15	26	antagonists	antagonist	NOUN
clinmedi-42	15	27	,	,	PUNCT
clinmedi-42	15	28	short	short	ADJ
clinmedi-42	15	29	course	course	NOUN
clinmedi-42	15	30	corticosteroids	corticosteroid	NOUN
clinmedi-42	15	31	and	and	CCONJ
clinmedi-42	15	32	omalizumab	omalizumab	NOUN
clinmedi-42	15	33	if	if	SCONJ
clinmedi-42	15	34	severe	severe	ADJ
clinmedi-42	15	35	with	with	ADP
clinmedi-42	15	36	or	or	CCONJ
clinmedi-42	15	37	without	without	ADP
clinmedi-42	15	38	angioedema	angioedema	NOUN
clinmedi-42	15	39	[	[	X
clinmedi-42	15	40	1	1	NUM
clinmedi-42	15	41	]	]	PUNCT
clinmedi-42	15	42	.	.	PUNCT
clinmedi-42	16	1	in	in	ADP
clinmedi-42	16	2	the	the	DET
clinmedi-42	16	3	present	present	ADJ
clinmedi-42	16	4	article	article	NOUN
clinmedi-42	16	5	,	,	PUNCT
clinmedi-42	16	6	we	we	PRON
clinmedi-42	16	7	describe	describe	VERB
clinmedi-42	16	8	our	our	PRON
clinmedi-42	16	9	experience	experience	NOUN
clinmedi-42	16	10	with	with	ADP
clinmedi-42	16	11	treatment	treatment	NOUN
clinmedi-42	16	12	of	of	ADP
clinmedi-42	16	13	systemic	systemic	ADJ
clinmedi-42	16	14	and	and	CCONJ
clinmedi-42	16	15	idiopathic	idiopathic	ADJ
clinmedi-42	16	16	cu	cu	PROPN
clinmedi-42	16	17	with	with	ADP
clinmedi-42	16	18	rituximab	rituximab	NOUN
clinmedi-42	16	19	in	in	ADP
clinmedi-42	16	20	patients	patient	NOUN
clinmedi-42	16	21	who	who	PRON
clinmedi-42	16	22	had	have	AUX
clinmedi-42	16	23	failed	fail	VERB
clinmedi-42	16	24	multiple	multiple	ADJ
clinmedi-42	16	25	corticosteroid	corticosteroid	NOUN
clinmedi-42	16	26	-	-	PUNCT
clinmedi-42	16	27	sparing	spare	VERB
clinmedi-42	16	28	agents	agent	NOUN
clinmedi-42	16	29	.	.	PUNCT
clinmedi-42	17	1	patients	patient	NOUN
clinmedi-42	17	2	and	and	CCONJ
clinmedi-42	17	3	methods	method	NOUN
clinmedi-42	17	4	:	:	PUNCT
clinmedi-42	17	5	inclusion	inclusion	NOUN
clinmedi-42	17	6	criteria	criterion	NOUN
clinmedi-42	17	7	:	:	PUNCT
clinmedi-42	17	8	all	all	DET
clinmedi-42	17	9	patients	patient	NOUN
clinmedi-42	17	10	,	,	PUNCT
clinmedi-42	17	11	with	with	ADP
clinmedi-42	17	12	generalized	generalized	ADJ
clinmedi-42	17	13	purpuric	purpuric	ADJ
clinmedi-42	17	14	wheals	wheal	NOUN
clinmedi-42	17	15	with	with	ADP
clinmedi-42	17	16	surrounding	surround	VERB
clinmedi-42	17	17	erythema	erythema	NOUN
clinmedi-42	17	18	which	which	PRON
clinmedi-42	17	19	persisted	persist	VERB
clinmedi-42	17	20	for	for	ADP
clinmedi-42	17	21	>	>	X
clinmedi-42	17	22	6	6	NUM
clinmedi-42	17	23	weeks	week	NOUN
clinmedi-42	17	24	,	,	PUNCT
clinmedi-42	17	25	were	be	AUX
clinmedi-42	17	26	seen	see	VERB
clinmedi-42	17	27	in	in	ADP
clinmedi-42	17	28	the	the	DET
clinmedi-42	17	29	past	past	ADJ
clinmedi-42	17	30	2	2	NUM
clinmedi-42	17	31	years	year	NOUN
clinmedi-42	17	32	.	.	PUNCT
clinmedi-42	18	1	all	all	DET
clinmedi-42	18	2	patients	patient	NOUN
clinmedi-42	18	3	had	have	VERB
clinmedi-42	18	4	the	the	DET
clinmedi-42	18	5	following	follow	VERB
clinmedi-42	18	6	criteria	criterion	NOUN
clinmedi-42	18	7	:	:	PUNCT
clinmedi-42	18	8	(	(	PUNCT
clinmedi-42	18	9	a	a	X
clinmedi-42	18	10	)	)	PUNCT
clinmedi-42	18	11	high	high	ADJ
clinmedi-42	18	12	ige	ige	PROPN
clinmedi-42	18	13	levels	level	NOUN
clinmedi-42	18	14	with	with	ADP
clinmedi-42	18	15	/	/	SYM
clinmedi-42	18	16	without	without	ADP
clinmedi-42	18	17	previous	previous	ADJ
clinmedi-42	18	18	history	history	NOUN
clinmedi-42	18	19	of	of	ADP
clinmedi-42	18	20	atopy	atopy	NOUN
clinmedi-42	18	21	and/or	and/or	CCONJ
clinmedi-42	18	22	bronchial	bronchial	ADJ
clinmedi-42	18	23	asthma	asthma	NOUN
clinmedi-42	18	24	.	.	PUNCT
clinmedi-42	19	1	(	(	PUNCT
clinmedi-42	19	2	b	b	X
clinmedi-42	19	3	)	)	PUNCT
clinmedi-42	19	4	none	none	NOUN
clinmedi-42	19	5	had	have	VERB
clinmedi-42	19	6	secondary	secondary	ADJ
clinmedi-42	19	7	cause	cause	NOUN
clinmedi-42	19	8	for	for	ADP
clinmedi-42	19	9	allergy	allergy	NOUN
clinmedi-42	19	10	viz	viz	PROPN
clinmedi-42	19	11	.	.	PUNCT
clinmedi-42	20	1	malignancy	malignancy	PROPN
clinmedi-42	20	2	,	,	PUNCT
clinmedi-42	20	3	infections	infection	NOUN
clinmedi-42	20	4	and	and	CCONJ
clinmedi-42	20	5	parasitic	parasitic	ADJ
clinmedi-42	20	6	infestations	infestation	NOUN
clinmedi-42	20	7	(	(	PUNCT
clinmedi-42	20	8	c	c	X
clinmedi-42	20	9	)	)	PUNCT
clinmedi-42	20	10	no	no	DET
clinmedi-42	20	11	evidence	evidence	NOUN
clinmedi-42	20	12	of	of	ADP
clinmedi-42	20	13	physical	physical	ADJ
clinmedi-42	20	14	cause	cause	NOUN
clinmedi-42	20	15	for	for	ADP
clinmedi-42	20	16	their	their	PRON
clinmedi-42	20	17	illness	illness	NOUN
clinmedi-42	20	18	(	(	PUNCT
clinmedi-42	20	19	heat	heat	NOUN
clinmedi-42	20	20	,	,	PUNCT
clinmedi-42	20	21	cold	cold	ADJ
clinmedi-42	20	22	,	,	PUNCT
clinmedi-42	20	23	solar	solar	ADJ
clinmedi-42	20	24	,	,	PUNCT
clinmedi-42	20	25	vibration	vibration	NOUN
clinmedi-42	20	26	,	,	PUNCT
clinmedi-42	20	27	delayed	delay	VERB
clinmedi-42	20	28	-	-	PUNCT
clinmedi-42	20	29	pressure	pressure	NOUN
clinmedi-42	20	30	,	,	PUNCT
clinmedi-42	20	31	dermatographism	dermatographism	NOUN
clinmedi-42	20	32	,	,	PUNCT
clinmedi-42	20	33	aquagenic	aquagenic	ADJ
clinmedi-42	20	34	and	and	CCONJ
clinmedi-42	20	35	cholinergic	cholinergic	ADJ
clinmedi-42	20	36	induced	induced	ADJ
clinmedi-42	20	37	urticaria	urticaria	NOUN
clinmedi-42	20	38	)	)	PUNCT
clinmedi-42	20	39	which	which	PRON
clinmedi-42	20	40	was	be	AUX
clinmedi-42	20	41	confirmed	confirm	VERB
clinmedi-42	20	42	with	with	ADP
clinmedi-42	20	43	skin	skin	NOUN
clinmedi-42	20	44	testing	testing	NOUN
clinmedi-42	20	45	.	.	PUNCT
clinmedi-42	21	1	the	the	DET
clinmedi-42	21	2	latter	latter	ADJ
clinmedi-42	21	3	included	include	VERB
clinmedi-42	21	4	;	;	PUNCT
clinmedi-42	21	5	wet	wet	ADJ
clinmedi-42	21	6	cloth	cloth	NOUN
clinmedi-42	21	7	,	,	PUNCT
clinmedi-42	21	8	hot	hot	ADJ
clinmedi-42	21	9	bath	bath	NOUN
clinmedi-42	21	10	,	,	PUNCT
clinmedi-42	21	11	prick	prick	VERB
clinmedi-42	21	12	/	/	SYM
clinmedi-42	21	13	patch	patch	NOUN
clinmedi-42	21	14	tests	test	NOUN
clinmedi-42	21	15	(	(	PUNCT
clinmedi-42	21	16	d	d	X
clinmedi-42	21	17	)	)	PUNCT
clinmedi-42	21	18	no	no	DET
clinmedi-42	21	19	clinical	clinical	ADJ
clinmedi-42	21	20	evidence	evidence	NOUN
clinmedi-42	21	21	of	of	ADP
clinmedi-42	21	22	food	food	NOUN
clinmedi-42	21	23	-	-	PUNCT
clinmedi-42	21	24	association	association	NOUN
clinmedi-42	21	25	(	(	PUNCT
clinmedi-42	21	26	e	e	NOUN
clinmedi-42	21	27	)	)	PUNCT
clinmedi-42	21	28	no	no	DET
clinmedi-42	21	29	evidence	evidence	NOUN
clinmedi-42	21	30	of	of	ADP
clinmedi-42	21	31	new	new	ADJ
clinmedi-42	21	32	drug	drug	NOUN
clinmedi-42	21	33	addition	addition	NOUN
clinmedi-42	21	34	especially	especially	ADV
clinmedi-42	21	35	acei	acei	PROPN
clinmedi-42	21	36	,	,	PUNCT
clinmedi-42	21	37	arb	arb	PROPN
clinmedi-42	21	38	,	,	PUNCT
clinmedi-42	21	39	oral	oral	ADJ
clinmedi-42	21	40	contraceptives	contraceptive	NOUN
clinmedi-42	21	41	and	and	CCONJ
clinmedi-42	21	42	all	all	DET
clinmedi-42	21	43	drugs	drug	NOUN
clinmedi-42	21	44	were	be	AUX
clinmedi-42	21	45	tested	test	VERB
clinmedi-42	21	46	by	by	ADP
clinmedi-42	21	47	a	a	DET
clinmedi-42	21	48	2	2	NUM
clinmedi-42	21	49	-	-	PUNCT
clinmedi-42	21	50	weeks	week	NOUN
clinmedi-42	21	51	discontinuation	discontinuation	NOUN
clinmedi-42	21	52	period	period	NOUN
clinmedi-42	21	53	.	.	PUNCT
clinmedi-42	22	1	(	(	PUNCT
clinmedi-42	22	2	f	f	X
clinmedi-42	22	3	)	)	PUNCT
clinmedi-42	22	4	skin	skin	NOUN
clinmedi-42	22	5	biopsy	biopsy	NOUN
clinmedi-42	22	6	that	that	PRON
clinmedi-42	22	7	did	do	AUX
clinmedi-42	22	8	not	not	PART
clinmedi-42	22	9	show	show	VERB
clinmedi-42	22	10	vasculitis	vasculitis	PROPN
clinmedi-42	22	11	(	(	PUNCT
clinmedi-42	22	12	g	g	NOUN
clinmedi-42	22	13	)	)	PUNCT
clinmedi-42	22	14	normal	normal	ADJ
clinmedi-42	22	15	tsh	tsh	NOUN
clinmedi-42	22	16	,	,	PUNCT
clinmedi-42	22	17	crp	crp	PROPN
clinmedi-42	22	18	,	,	PUNCT
clinmedi-42	22	19	iga	iga	PROPN
clinmedi-42	22	20	level	level	NOUN
clinmedi-42	22	21	,	,	PUNCT
clinmedi-42	22	22	hepatitis	hepatitis	PROPN
clinmedi-42	22	23	b	b	PROPN
clinmedi-42	22	24	&	&	CCONJ
clinmedi-42	22	25	c	c	PROPN
clinmedi-42	22	26	serology	serology	NOUN
clinmedi-42	22	27	,	,	PUNCT
clinmedi-42	22	28	helicobacter	helicobacter	NOUN
clinmedi-42	22	29	antibodies	antibody	NOUN
clinmedi-42	22	30	,	,	PUNCT
clinmedi-42	22	31	antimicrosomal	antimicrosomal	PROPN
clinmedi-42	22	32	antibodies	antibodie	VERB
clinmedi-42	22	33	,	,	PUNCT
clinmedi-42	22	34	serum	serum	NOUN
clinmedi-42	22	35	protein	protein	NOUN
clinmedi-42	22	36	electrophoresis	electrophoresis	NOUN
clinmedi-42	22	37	,	,	PUNCT
clinmedi-42	22	38	ra	ra	PROPN
clinmedi-42	22	39	,	,	PUNCT
clinmedi-42	22	40	anca	anca	PROPN
clinmedi-42	22	41	,	,	PUNCT
clinmedi-42	22	42	ana	ana	PROPN
clinmedi-42	22	43	,	,	PUNCT
clinmedi-42	22	44	and	and	CCONJ
clinmedi-42	22	45	serum	serum	NOUN
clinmedi-42	22	46	complements	complement	NOUN
clinmedi-42	22	47	.	.	PUNCT
clinmedi-42	23	1	treatment	treatment	NOUN
clinmedi-42	23	2	protocol	protocol	NOUN
clinmedi-42	23	3	:	:	PUNCT
clinmedi-42	23	4	all	all	DET
clinmedi-42	23	5	patients	patient	NOUN
clinmedi-42	23	6	were	be	AUX
clinmedi-42	23	7	treated	treat	VERB
clinmedi-42	23	8	with	with	ADP
clinmedi-42	23	9	prednisone	prednisone	PROPN
clinmedi-42	23	10	1	1	NUM
clinmedi-42	23	11	mg	mg	PROPN
clinmedi-42	23	12	/	/	SYM
clinmedi-42	23	13	kg	kg	PROPN
clinmedi-42	23	14	for	for	ADP
clinmedi-42	23	15	a	a	DET
clinmedi-42	23	16	minimum	minimum	NOUN
clinmedi-42	23	17	of	of	ADP
clinmedi-42	23	18	1	1	NUM
clinmedi-42	23	19	month	month	NOUN
clinmedi-42	23	20	.	.	PUNCT
clinmedi-42	24	1	subsequently	subsequently	ADV
clinmedi-42	24	2	,	,	PUNCT
clinmedi-42	24	3	the	the	DET
clinmedi-42	24	4	dose	dose	NOUN
clinmedi-42	24	5	was	be	AUX
clinmedi-42	24	6	decreased	decrease	VERB
clinmedi-42	24	7	by	by	ADP
clinmedi-42	24	8	5	5	NUM
clinmedi-42	24	9	mg	mg	NUM
clinmedi-42	24	10	/	/	SYM
clinmedi-42	24	11	week	week	NOUN
clinmedi-42	24	12	.	.	PUNCT
clinmedi-42	25	1	if	if	SCONJ
clinmedi-42	25	2	fails	fail	VERB
clinmedi-42	25	3	to	to	PART
clinmedi-42	25	4	maintain	maintain	VERB
clinmedi-42	25	5	a	a	DET
clinmedi-42	25	6	remission	remission	NOUN
clinmedi-42	25	7	for	for	ADP
clinmedi-42	25	8	>	>	X
clinmedi-42	25	9	2	2	NUM
clinmedi-42	25	10	weeks	week	NOUN
clinmedi-42	25	11	;	;	PUNCT
clinmedi-42	25	12	intravenous	intravenous	ADJ
clinmedi-42	25	13	immunoglobulin	immunoglobulin	NOUN
clinmedi-42	25	14	(	(	PUNCT
clinmedi-42	25	15	ivig	ivig	NOUN
clinmedi-42	25	16	)	)	PUNCT
clinmedi-42	25	17	is	be	AUX
clinmedi-42	25	18	used	use	VERB
clinmedi-42	25	19	.	.	PUNCT
clinmedi-42	26	1	if	if	SCONJ
clinmedi-42	26	2	the	the	DET
clinmedi-42	26	3	latter	latter	ADJ
clinmedi-42	26	4	fails	fail	VERB
clinmedi-42	26	5	,	,	PUNCT
clinmedi-42	26	6	another	another	DET
clinmedi-42	26	7	2	2	NUM
clinmedi-42	26	8	-	-	PUNCT
clinmedi-42	26	9	weeks	week	NOUN
clinmedi-42	26	10	trial	trial	NOUN
clinmedi-42	26	11	of	of	ADP
clinmedi-42	26	12	mycophenolate	mycophenolate	ADJ
clinmedi-42	26	13	mofetil	mofetil	PROPN
clinmedi-42	26	14	with	with	ADP
clinmedi-42	26	15	hydroxychloroquine	hydroxychloroquine	PROPN
clinmedi-42	26	16	and	and	CCONJ
clinmedi-42	26	17	tacrolimus	tacrolimus	NOUN
clinmedi-42	26	18	is	be	AUX
clinmedi-42	26	19	used	use	VERB
clinmedi-42	26	20	.	.	PUNCT
clinmedi-42	27	1	if	if	SCONJ
clinmedi-42	27	2	fails	fail	VERB
clinmedi-42	27	3	again	again	ADV
clinmedi-42	27	4	;	;	PUNCT
clinmedi-42	27	5	rituximab	rituximab	NOUN
clinmedi-42	27	6	infusions	infusion	NOUN
clinmedi-42	27	7	are	be	AUX
clinmedi-42	27	8	to	to	PART
clinmedi-42	27	9	be	be	AUX
clinmedi-42	27	10	given	give	VERB
clinmedi-42	27	11	.	.	PUNCT
clinmedi-42	28	1	rituximab	rituximab	NOUN
clinmedi-42	28	2	treatment	treatment	NOUN
clinmedi-42	28	3	for	for	ADP
clinmedi-42	28	4	chronic	chronic	ADJ
clinmedi-42	28	5	idiopathic	idiopathic	ADJ
clinmedi-42	28	6	urticaria	urticaria	NOUN
clinmedi-42	28	7	with	with	ADP
clinmedi-42	28	8	recurrent	recurrent	ADJ
clinmedi-42	28	9	angioedema	angioedema	NOUN
clinmedi-42	28	10	clinical	clinical	ADJ
clinmedi-42	28	11	medicine	medicine	NOUN
clinmedi-42	28	12	insights	insight	NOUN
clinmedi-42	28	13	page	page	VERB
clinmedi-42	28	14	7	7	NUM
clinmedi-42	28	15	rituximab	rituximab	NOUN
clinmedi-42	28	16	infusions	infusion	NOUN
clinmedi-42	28	17	:	:	PUNCT
clinmedi-42	28	18	the	the	DET
clinmedi-42	28	19	patients	patient	NOUN
clinmedi-42	28	20	were	be	AUX
clinmedi-42	28	21	treated	treat	VERB
clinmedi-42	28	22	with	with	ADP
clinmedi-42	28	23	four	four	NUM
clinmedi-42	28	24	weekly	weekly	ADJ
clinmedi-42	28	25	infusions	infusion	NOUN
clinmedi-42	28	26	of	of	ADP
clinmedi-42	28	27	500	500	NUM
clinmedi-42	28	28	mg	mg	NOUN
clinmedi-42	28	29	of	of	ADP
clinmedi-42	28	30	rituximab	rituximab	NOUN
clinmedi-42	28	31	(	(	PUNCT
clinmedi-42	28	32	mabthera	mabthera	NOUN
clinmedi-42	28	33	)	)	PUNCT
clinmedi-42	28	34	.	.	PUNCT
clinmedi-42	29	1	the	the	DET
clinmedi-42	29	2	patient	patient	NOUN
clinmedi-42	29	3	was	be	AUX
clinmedi-42	29	4	pre	pre	VERB
clinmedi-42	29	5	-	-	VERB
clinmedi-42	29	6	medicated	medicated	ADJ
clinmedi-42	29	7	with	with	ADP
clinmedi-42	29	8	two	two	NUM
clinmedi-42	29	9	500	500	NUM
clinmedi-42	29	10	mg	mg	NOUN
clinmedi-42	29	11	paracetamol	paracetamol	NOUN
clinmedi-42	29	12	and	and	CCONJ
clinmedi-42	29	13	one	one	NUM
clinmedi-42	29	14	piriton	piriton	NOUN
clinmedi-42	29	15	tablets	tablet	NOUN
clinmedi-42	29	16	followed	follow	VERB
clinmedi-42	29	17	by	by	ADP
clinmedi-42	29	18	an	an	DET
clinmedi-42	29	19	infusion	infusion	NOUN
clinmedi-42	29	20	of	of	ADP
clinmedi-42	29	21	125	125	NUM
clinmedi-42	29	22	mg	mg	NOUN
clinmedi-42	29	23	of	of	ADP
clinmedi-42	29	24	solumedrol	solumedrol	NOUN
clinmedi-42	29	25	in	in	ADP
clinmedi-42	29	26	50	50	NUM
clinmedi-42	29	27	ml	ml	NOUN
clinmedi-42	29	28	of	of	ADP
clinmedi-42	29	29	d5w	d5w	PROPN
clinmedi-42	29	30	over	over	ADP
clinmedi-42	29	31	30	30	NUM
clinmedi-42	29	32	minutes	minute	NOUN
clinmedi-42	29	33	before	before	ADP
clinmedi-42	29	34	infusions	infusion	NOUN
clinmedi-42	29	35	.	.	PUNCT
clinmedi-42	30	1	the	the	DET
clinmedi-42	30	2	500	500	NUM
clinmedi-42	30	3	mg	mg	NOUN
clinmedi-42	30	4	of	of	ADP
clinmedi-42	30	5	rituximab	rituximab	NOUN
clinmedi-42	30	6	was	be	AUX
clinmedi-42	30	7	diluted	dilute	VERB
clinmedi-42	30	8	in	in	ADP
clinmedi-42	30	9	450	450	NUM
clinmedi-42	30	10	ml	ml	NOUN
clinmedi-42	30	11	of	of	ADP
clinmedi-42	30	12	ns	ns	NUM
clinmedi-42	30	13	leading	lead	VERB
clinmedi-42	30	14	to	to	ADP
clinmedi-42	30	15	a	a	DET
clinmedi-42	30	16	concentration	concentration	NOUN
clinmedi-42	30	17	of	of	ADP
clinmedi-42	30	18	1	1	NUM
clinmedi-42	30	19	mg	mg	NUM
clinmedi-42	30	20	/	/	SYM
clinmedi-42	30	21	ml	ml	NOUN
clinmedi-42	30	22	.	.	PUNCT
clinmedi-42	31	1	the	the	DET
clinmedi-42	31	2	first	first	ADJ
clinmedi-42	31	3	infusion	infusion	NOUN
clinmedi-42	31	4	rate	rate	NOUN
clinmedi-42	31	5	was	be	AUX
clinmedi-42	31	6	20	20	NUM
clinmedi-42	31	7	ml	ml	NOUN
clinmedi-42	31	8	/	/	SYM
clinmedi-42	31	9	h	h	NOUN
clinmedi-42	31	10	for	for	ADP
clinmedi-42	31	11	the	the	DET
clinmedi-42	31	12	first	first	ADJ
clinmedi-42	31	13	30	30	NUM
clinmedi-42	31	14	minutes	minute	NOUN
clinmedi-42	31	15	followed	follow	VERB
clinmedi-42	31	16	by	by	ADP
clinmedi-42	31	17	20	20	NUM
clinmedi-42	31	18	ml	ml	NOUN
clinmedi-42	31	19	increments	increment	NOUN
clinmedi-42	31	20	/	/	SYM
clinmedi-42	31	21	hour	hour	NOUN
clinmedi-42	31	22	every	every	DET
clinmedi-42	31	23	30	30	NUM
clinmedi-42	31	24	minutes	minute	NOUN
clinmedi-42	31	25	till	till	SCONJ
clinmedi-42	31	26	the	the	DET
clinmedi-42	31	27	total	total	ADJ
clinmedi-42	31	28	dose	dose	NOUN
clinmedi-42	31	29	is	be	AUX
clinmedi-42	31	30	achieved	achieve	VERB
clinmedi-42	31	31	.	.	PUNCT
clinmedi-42	32	1	the	the	DET
clinmedi-42	32	2	second	second	ADJ
clinmedi-42	32	3	infusion	infusion	NOUN
clinmedi-42	32	4	was	be	AUX
clinmedi-42	32	5	a	a	DET
clinmedi-42	32	6	rate	rate	NOUN
clinmedi-42	32	7	was	be	AUX
clinmedi-42	32	8	started	start	VERB
clinmedi-42	32	9	at	at	ADP
clinmedi-42	32	10	40	40	NUM
clinmedi-42	32	11	ml	ml	NOUN
clinmedi-42	32	12	/	/	SYM
clinmedi-42	32	13	hour	hour	NOUN
clinmedi-42	32	14	,	,	PUNCT
clinmedi-42	32	15	the	the	DET
clinmedi-42	32	16	third	third	ADJ
clinmedi-42	32	17	at	at	ADP
clinmedi-42	32	18	80	80	NUM
clinmedi-42	32	19	ml	ml	NOUN
clinmedi-42	32	20	/	/	SYM
clinmedi-42	32	21	hour	hour	NOUN
clinmedi-42	32	22	and	and	CCONJ
clinmedi-42	32	23	the	the	DET
clinmedi-42	32	24	fourth	fourth	ADJ
clinmedi-42	32	25	at	at	ADP
clinmedi-42	32	26	120	120	NUM
clinmedi-42	32	27	ml	ml	NOUN
clinmedi-42	32	28	/	/	SYM
clinmedi-42	32	29	hour	hour	NOUN
clinmedi-42	32	30	.	.	PUNCT
clinmedi-42	33	1	flow	flow	NOUN
clinmedi-42	33	2	cytometry	cytometry	NOUN
clinmedi-42	33	3	showed	show	VERB
clinmedi-42	33	4	that	that	SCONJ
clinmedi-42	33	5	her	her	PRON
clinmedi-42	33	6	cd19	cd19	PROPN
clinmedi-42	33	7	lymphocytes	lymphocyte	NOUN
clinmedi-42	33	8	dropped	drop	VERB
clinmedi-42	33	9	to	to	ADP
clinmedi-42	33	10	zero	zero	NUM
clinmedi-42	33	11	after	after	ADP
clinmedi-42	33	12	one	one	NUM
clinmedi-42	33	13	week	week	NOUN
clinmedi-42	33	14	of	of	ADP
clinmedi-42	33	15	therapy	therapy	NOUN
clinmedi-42	33	16	and	and	CCONJ
clinmedi-42	33	17	remained	remain	VERB
clinmedi-42	33	18	<	<	X
clinmedi-42	33	19	0.5	0.5	NUM
clinmedi-42	33	20	%	%	NOUN
clinmedi-42	33	21	for	for	ADP
clinmedi-42	33	22	8	8	NUM
clinmedi-42	33	23	months	month	NOUN
clinmedi-42	33	24	.	.	PUNCT
clinmedi-42	34	1	interestingly	interestingly	ADV
clinmedi-42	34	2	,	,	PUNCT
clinmedi-42	34	3	the	the	DET
clinmedi-42	34	4	patient	patient	NOUN
clinmedi-42	34	5	is	be	AUX
clinmedi-42	34	6	asymptomatic	asymptomatic	ADJ
clinmedi-42	34	7	and	and	CCONJ
clinmedi-42	34	8	up	up	ADV
clinmedi-42	34	9	to	to	PART
clinmedi-42	34	10	12	12	NUM
clinmedi-42	34	11	months	month	NOUN
clinmedi-42	34	12	after	after	ADP
clinmedi-42	34	13	normalization	normalization	NOUN
clinmedi-42	34	14	of	of	ADP
clinmedi-42	34	15	her	her	PRON
clinmedi-42	34	16	cd19	cd19	PROPN
clinmedi-42	34	17	i.e.	i.e.	X
clinmedi-42	34	18	total	total	NOUN
clinmedi-42	34	19	of	of	ADP
clinmedi-42	34	20	20	20	NUM
clinmedi-42	34	21	months	month	NOUN
clinmedi-42	34	22	following	follow	VERB
clinmedi-42	34	23	the	the	DET
clinmedi-42	34	24	start	start	NOUN
clinmedi-42	34	25	of	of	ADP
clinmedi-42	34	26	rituximab	rituximab	NOUN
clinmedi-42	34	27	therapy	therapy	NOUN
clinmedi-42	34	28	.	.	PUNCT
clinmedi-42	35	1	results	result	VERB
clinmedi-42	35	2	a	a	DET
clinmedi-42	35	3	total	total	NOUN
clinmedi-42	35	4	of	of	ADP
clinmedi-42	35	5	4	4	NUM
clinmedi-42	35	6	patients	patient	NOUN
clinmedi-42	35	7	fullfiled	fullfile	VERB
clinmedi-42	35	8	the	the	DET
clinmedi-42	35	9	inclusion	inclusion	NOUN
clinmedi-42	35	10	criteria	criterion	NOUN
clinmedi-42	35	11	and	and	CCONJ
clinmedi-42	35	12	hence	hence	ADV
clinmedi-42	35	13	were	be	AUX
clinmedi-42	35	14	included	include	VERB
clinmedi-42	35	15	in	in	ADP
clinmedi-42	35	16	the	the	DET
clinmedi-42	35	17	study	study	NOUN
clinmedi-42	35	18	)	)	PUNCT
clinmedi-42	35	19	.	.	PUNCT
clinmedi-42	36	1	all	all	DET
clinmedi-42	36	2	patients	patient	NOUN
clinmedi-42	36	3	were	be	AUX
clinmedi-42	36	4	adults	adult	NOUN
clinmedi-42	36	5	(	(	PUNCT
clinmedi-42	36	6	26	26	NUM
clinmedi-42	36	7	-	-	SYM
clinmedi-42	36	8	50	50	NUM
clinmedi-42	36	9	years	year	NOUN
clinmedi-42	36	10	)	)	PUNCT
clinmedi-42	36	11	and	and	CCONJ
clinmedi-42	36	12	had	have	VERB
clinmedi-42	36	13	cu	cu	NOUN
clinmedi-42	36	14	for	for	ADP
clinmedi-42	36	15	>	>	SYM
clinmedi-42	36	16	6	6	NUM
clinmedi-42	36	17	-	-	SYM
clinmedi-42	36	18	8	8	NUM
clinmedi-42	36	19	months	month	NOUN
clinmedi-42	36	20	prior	prior	ADV
clinmedi-42	36	21	to	to	ADP
clinmedi-42	36	22	inclusion	inclusion	NOUN
clinmedi-42	36	23	in	in	ADP
clinmedi-42	36	24	the	the	DET
clinmedi-42	36	25	study	study	NOUN
clinmedi-42	36	26	all	all	DET
clinmedi-42	36	27	patients	patient	NOUN
clinmedi-42	36	28	had	have	VERB
clinmedi-42	36	29	recurrent	recurrent	ADJ
clinmedi-42	36	30	attacks	attack	NOUN
clinmedi-42	36	31	of	of	ADP
clinmedi-42	36	32	angioneurotic	angioneurotic	ADJ
clinmedi-42	36	33	oedema	oedema	NOUN
clinmedi-42	36	34	that	that	PRON
clinmedi-42	36	35	had	have	AUX
clinmedi-42	36	36	required	require	VERB
clinmedi-42	36	37	multiple	multiple	ADJ
clinmedi-42	36	38	hospital	hospital	NOUN
clinmedi-42	36	39	admissions	admission	NOUN
clinmedi-42	36	40	.	.	PUNCT
clinmedi-42	37	1	efficacy	efficacy	NOUN
clinmedi-42	37	2	of	of	ADP
clinmedi-42	37	3	rituximab	rituximab	NOUN
clinmedi-42	37	4	:	:	PUNCT
clinmedi-42	37	5	the	the	DET
clinmedi-42	37	6	drug	drug	NOUN
clinmedi-42	37	7	was	be	AUX
clinmedi-42	37	8	tolerable	tolerable	ADJ
clinmedi-42	37	9	on	on	ADP
clinmedi-42	37	10	such	such	ADJ
clinmedi-42	37	11	dosage	dosage	NOUN
clinmedi-42	37	12	despite	despite	SCONJ
clinmedi-42	37	13	4	4	NUM
clinmedi-42	37	14	-	-	SYM
clinmedi-42	37	15	6	6	NUM
clinmedi-42	37	16	hour	hour	NOUN
clinmedi-42	37	17	infusion	infusion	NOUN
clinmedi-42	37	18	time	time	NOUN
clinmedi-42	37	19	.	.	PUNCT
clinmedi-42	38	1	there	there	PRON
clinmedi-42	38	2	were	be	VERB
clinmedi-42	38	3	no	no	DET
clinmedi-42	38	4	post	post	ADJ
clinmedi-42	38	5	-	-	ADJ
clinmedi-42	38	6	infusion	infusion	ADJ
clinmedi-42	38	7	immediate	immediate	ADJ
clinmedi-42	38	8	reactions	reaction	NOUN
clinmedi-42	38	9	and	and	CCONJ
clinmedi-42	38	10	there	there	PRON
clinmedi-42	38	11	was	be	VERB
clinmedi-42	38	12	no	no	DET
clinmedi-42	38	13	report	report	NOUN
clinmedi-42	38	14	of	of	ADP
clinmedi-42	38	15	delayed	delay	VERB
clinmedi-42	38	16	side	side	NOUN
clinmedi-42	38	17	effect	effect	NOUN
clinmedi-42	38	18	.	.	PUNCT
clinmedi-42	39	1	one	one	NUM
clinmedi-42	39	2	month	month	NOUN
clinmedi-42	39	3	after	after	ADP
clinmedi-42	39	4	the	the	DET
clinmedi-42	39	5	last	last	ADJ
clinmedi-42	39	6	dose	dose	NOUN
clinmedi-42	39	7	of	of	ADP
clinmedi-42	39	8	rituximab	rituximab	NOUN
clinmedi-42	39	9	;	;	PUNCT
clinmedi-42	39	10	prednisone	prednisone	PROPN
clinmedi-42	39	11	dose	dose	PROPN
clinmedi-42	39	12	was	be	AUX
clinmedi-42	39	13	tapered	taper	VERB
clinmedi-42	39	14	down	down	ADP
clinmedi-42	39	15	and	and	CCONJ
clinmedi-42	39	16	the	the	DET
clinmedi-42	39	17	drug	drug	NOUN
clinmedi-42	39	18	was	be	AUX
clinmedi-42	39	19	discontinued	discontinue	VERB
clinmedi-42	39	20	without	without	ADP
clinmedi-42	39	21	relapse	relapse	NOUN
clinmedi-42	39	22	of	of	ADP
clinmedi-42	39	23	their	their	PRON
clinmedi-42	39	24	urticaria	urticaria	NOUN
clinmedi-42	39	25	.	.	PUNCT
clinmedi-42	40	1	duration	duration	NOUN
clinmedi-42	40	2	of	of	ADP
clinmedi-42	40	3	follow	follow	VERB
clinmedi-42	40	4	up	up	ADP
clinmedi-42	40	5	:	:	PUNCT
clinmedi-42	40	6	the	the	DET
clinmedi-42	40	7	patients	patient	NOUN
clinmedi-42	40	8	were	be	AUX
clinmedi-42	40	9	followed	follow	VERB
clinmedi-42	40	10	up	up	ADP
clinmedi-42	40	11	for	for	ADP
clinmedi-42	40	12	>	>	X
clinmedi-42	40	13	14	14	NUM
clinmedi-42	40	14	months	month	NOUN
clinmedi-42	40	15	in	in	ADP
clinmedi-42	40	16	the	the	DET
clinmedi-42	40	17	last	last	ADJ
clinmedi-42	40	18	patient	patient	NOUN
clinmedi-42	40	19	and	and	CCONJ
clinmedi-42	40	20	up	up	ADP
clinmedi-42	40	21	to	to	PART
clinmedi-42	40	22	24	24	NUM
clinmedi-42	40	23	months	month	NOUN
clinmedi-42	40	24	in	in	ADP
clinmedi-42	40	25	the	the	DET
clinmedi-42	40	26	first	first	ADJ
clinmedi-42	40	27	patient	patient	NOUN
clinmedi-42	40	28	.	.	PUNCT
clinmedi-42	41	1	discussion	discussion	NOUN
clinmedi-42	41	2	urticaria	urticaria	NOUN
clinmedi-42	41	3	is	be	AUX
clinmedi-42	41	4	not	not	PART
clinmedi-42	41	5	a	a	DET
clinmedi-42	41	6	single	single	ADJ
clinmedi-42	41	7	disease	disease	NOUN
clinmedi-42	41	8	but	but	CCONJ
clinmedi-42	41	9	a	a	DET
clinmedi-42	41	10	reaction	reaction	NOUN
clinmedi-42	41	11	pattern	pattern	NOUN
clinmedi-42	41	12	that	that	PRON
clinmedi-42	41	13	represents	represent	VERB
clinmedi-42	41	14	cutaneous	cutaneous	ADJ
clinmedi-42	41	15	mast	mast	NOUN
clinmedi-42	41	16	cell	cell	NOUN
clinmedi-42	41	17	degranulation	degranulation	NOUN
clinmedi-42	41	18	.	.	PUNCT
clinmedi-42	42	1	the	the	DET
clinmedi-42	42	2	latter	latter	ADJ
clinmedi-42	42	3	results	result	NOUN
clinmedi-42	42	4	in	in	ADP
clinmedi-42	42	5	extravasation	extravasation	NOUN
clinmedi-42	42	6	of	of	ADP
clinmedi-42	42	7	plasma	plasma	NOUN
clinmedi-42	42	8	into	into	ADP
clinmedi-42	42	9	the	the	DET
clinmedi-42	42	10	dermis	dermis	NOUN
clinmedi-42	42	11	,	,	PUNCT
clinmedi-42	42	12	forming	form	VERB
clinmedi-42	42	13	the	the	DET
clinmedi-42	42	14	characteristic	characteristic	ADJ
clinmedi-42	42	15	hives	hive	NOUN
clinmedi-42	42	16	which	which	PRON
clinmedi-42	42	17	are	be	AUX
clinmedi-42	42	18	edematous	edematous	ADJ
clinmedi-42	42	19	pruritic	pruritic	ADJ
clinmedi-42	42	20	pink	pink	ADJ
clinmedi-42	42	21	wheals	wheal	NOUN
clinmedi-42	42	22	of	of	ADP
clinmedi-42	42	23	variable	variable	ADJ
clinmedi-42	42	24	size	size	NOUN
clinmedi-42	42	25	and	and	CCONJ
clinmedi-42	42	26	shape	shape	NOUN
clinmedi-42	42	27	.	.	PUNCT
clinmedi-42	43	1	the	the	DET
clinmedi-42	43	2	lesions	lesion	NOUN
clinmedi-42	43	3	may	may	AUX
clinmedi-42	43	4	be	be	AUX
clinmedi-42	43	5	associated	associate	VERB
clinmedi-42	43	6	with	with	ADP
clinmedi-42	43	7	angioedema	angioedema	NOUN
clinmedi-42	43	8	which	which	PRON
clinmedi-42	43	9	is	be	AUX
clinmedi-42	43	10	a	a	DET
clinmedi-42	43	11	swelling	swelling	NOUN
clinmedi-42	43	12	deeper	deep	ADJ
clinmedi-42	43	13	than	than	ADP
clinmedi-42	43	14	wheals	wheal	NOUN
clinmedi-42	43	15	and	and	CCONJ
clinmedi-42	43	16	may	may	AUX
clinmedi-42	43	17	affect	affect	VERB
clinmedi-42	43	18	mucosal	mucosal	NOUN
clinmedi-42	43	19	surfaces	surface	NOUN
clinmedi-42	43	20	with	with	ADP
clinmedi-42	43	21	typical	typical	ADJ
clinmedi-42	43	22	sites	site	NOUN
clinmedi-42	43	23	of	of	ADP
clinmedi-42	43	24	predilection	predilection	NOUN
clinmedi-42	43	25	that	that	PRON
clinmedi-42	43	26	include	include	VERB
clinmedi-42	43	27	the	the	DET
clinmedi-42	43	28	eyelids	eyelid	NOUN
clinmedi-42	43	29	,	,	PUNCT
clinmedi-42	43	30	lips	lip	NOUN
clinmedi-42	43	31	,	,	PUNCT
clinmedi-42	43	32	and	and	CCONJ
clinmedi-42	43	33	tongue	tongue	NOUN
clinmedi-42	44	1	[	[	X
clinmedi-42	44	2	5	5	NUM
clinmedi-42	44	3	]	]	PUNCT
clinmedi-42	44	4	.	.	PUNCT
clinmedi-42	45	1	urticaria	urticaria	PROPN
clinmedi-42	45	2	being	be	AUX
clinmedi-42	45	3	defined	define	VERB
clinmedi-42	45	4	as	as	ADP
clinmedi-42	45	5	chronic	chronic	ADJ
clinmedi-42	45	6	if	if	SCONJ
clinmedi-42	45	7	lesions	lesion	NOUN
clinmedi-42	45	8	recur	recur	VERB
clinmedi-42	45	9	for	for	ADP
clinmedi-42	45	10	longer	long	ADJ
clinmedi-42	45	11	than	than	ADP
clinmedi-42	45	12	6	6	NUM
clinmedi-42	45	13	weeks	week	NOUN
clinmedi-42	45	14	.	.	PUNCT
clinmedi-42	46	1	cu	cu	PROPN
clinmedi-42	46	2	includes	include	VERB
clinmedi-42	46	3	physical	physical	ADJ
clinmedi-42	46	4	urticaria	urticaria	NOUN
clinmedi-42	46	5	,	,	PUNCT
clinmedi-42	46	6	idiopathic	idiopathic	ADJ
clinmedi-42	46	7	urticaria	urticaria	NOUN
clinmedi-42	46	8	,	,	PUNCT
clinmedi-42	46	9	and	and	CCONJ
clinmedi-42	46	10	urticarial	urticarial	ADJ
clinmedi-42	46	11	vasculitis	vasculitis	PROPN
clinmedi-42	46	12	[	[	X
clinmedi-42	46	13	1	1	NUM
clinmedi-42	46	14	]	]	PUNCT
clinmedi-42	46	15	.	.	PUNCT
clinmedi-42	47	1	in	in	ADP
clinmedi-42	47	2	our	our	PRON
clinmedi-42	47	3	study	study	NOUN
clinmedi-42	47	4	,	,	PUNCT
clinmedi-42	47	5	we	we	PRON
clinmedi-42	47	6	included	include	VERB
clinmedi-42	47	7	patients	patient	NOUN
clinmedi-42	47	8	with	with	ADP
clinmedi-42	47	9	idiopathic	idiopathic	ADJ
clinmedi-42	47	10	type	type	NOUN
clinmedi-42	47	11	of	of	ADP
clinmedi-42	47	12	cu	cu	PROPN
clinmedi-42	47	13	and	and	CCONJ
clinmedi-42	47	14	excluded	exclude	VERB
clinmedi-42	47	15	those	those	PRON
clinmedi-42	47	16	with	with	ADP
clinmedi-42	47	17	physical	physical	ADJ
clinmedi-42	47	18	and	and	CCONJ
clinmedi-42	47	19	vasculitic	vasculitic	ADJ
clinmedi-42	47	20	ones	one	NOUN
clinmedi-42	47	21	[	[	X
clinmedi-42	47	22	6	6	NUM
clinmedi-42	47	23	,	,	PUNCT
clinmedi-42	47	24	7	7	NUM
clinmedi-42	47	25	]	]	PUNCT
clinmedi-42	47	26	.	.	PUNCT
clinmedi-42	48	1	idiopathic	idiopathic	PROPN
clinmedi-42	48	2	cu	cu	PROPN
clinmedi-42	48	3	is	be	AUX
clinmedi-42	48	4	the	the	DET
clinmedi-42	48	5	most	most	ADV
clinmedi-42	48	6	common	common	ADJ
clinmedi-42	48	7	type	type	NOUN
clinmedi-42	48	8	,	,	PUNCT
clinmedi-42	48	9	comprising	comprise	VERB
clinmedi-42	48	10	up	up	ADP
clinmedi-42	48	11	to	to	PART
clinmedi-42	48	12	90	90	NUM
clinmedi-42	48	13	%	%	NOUN
clinmedi-42	48	14	of	of	ADP
clinmedi-42	48	15	all	all	DET
clinmedi-42	48	16	cases	case	NOUN
clinmedi-42	48	17	of	of	ADP
clinmedi-42	48	18	cu	cu	PROPN
clinmedi-42	48	19	.	.	PUNCT
clinmedi-42	49	1	it	it	PRON
clinmedi-42	49	2	has	have	AUX
clinmedi-42	49	3	been	be	AUX
clinmedi-42	49	4	estimated	estimate	VERB
clinmedi-42	49	5	that	that	SCONJ
clinmedi-42	49	6	idiopathic	idiopathic	ADJ
clinmedi-42	49	7	cu	cu	PROPN
clinmedi-42	49	8	affects	affect	VERB
clinmedi-42	49	9	between	between	ADP
clinmedi-42	49	10	0.6	0.6	NUM
clinmedi-42	49	11	%	%	NOUN
clinmedi-42	49	12	to	to	PART
clinmedi-42	49	13	5	5	NUM
clinmedi-42	49	14	%	%	NOUN
clinmedi-42	49	15	of	of	ADP
clinmedi-42	49	16	the	the	DET
clinmedi-42	49	17	population	population	NOUN
clinmedi-42	49	18	during	during	ADP
clinmedi-42	49	19	their	their	PRON
clinmedi-42	49	20	lifetime	lifetime	NOUN
clinmedi-42	50	1	[	[	X
clinmedi-42	50	2	8	8	NUM
clinmedi-42	50	3	]	]	PUNCT
clinmedi-42	50	4	.	.	PUNCT
clinmedi-42	51	1	over	over	ADP
clinmedi-42	51	2	half	half	NOUN
clinmedi-42	51	3	of	of	ADP
clinmedi-42	51	4	all	all	DET
clinmedi-42	51	5	cases	case	NOUN
clinmedi-42	51	6	of	of	ADP
clinmedi-42	51	7	idiopathic	idiopathic	ADJ
clinmedi-42	51	8	cu	cu	PROPN
clinmedi-42	51	9	are	be	AUX
clinmedi-42	51	10	thought	think	VERB
clinmedi-42	51	11	to	to	PART
clinmedi-42	51	12	be	be	AUX
clinmedi-42	51	13	caused	cause	VERB
clinmedi-42	51	14	by	by	ADP
clinmedi-42	51	15	an	an	DET
clinmedi-42	51	16	autoimmune	autoimmune	ADJ
clinmedi-42	51	17	mechanism	mechanism	NOUN
clinmedi-42	51	18	.	.	PUNCT
clinmedi-42	52	1	this	this	PRON
clinmedi-42	52	2	is	be	AUX
clinmedi-42	52	3	supported	support	VERB
clinmedi-42	52	4	by	by	ADP
clinmedi-42	52	5	the	the	DET
clinmedi-42	52	6	observation	observation	NOUN
clinmedi-42	52	7	that	that	SCONJ
clinmedi-42	52	8	60	60	NUM
clinmedi-42	52	9	%	%	NOUN
clinmedi-42	52	10	of	of	ADP
clinmedi-42	52	11	patients	patient	NOUN
clinmedi-42	52	12	with	with	ADP
clinmedi-42	52	13	idiopathic	idiopathic	ADJ
clinmedi-42	52	14	cu	cu	PROPN
clinmedi-42	52	15	will	will	AUX
clinmedi-42	52	16	have	have	AUX
clinmedi-42	52	17	a	a	DET
clinmedi-42	52	18	wheal	wheal	ADJ
clinmedi-42	52	19	and	and	CCONJ
clinmedi-42	52	20	flare	flare	NOUN
clinmedi-42	52	21	reaction	reaction	NOUN
clinmedi-42	52	22	to	to	AUX
clinmedi-42	52	23	intradermal	intradermal	ADJ
clinmedi-42	52	24	autologous	autologous	ADJ
clinmedi-42	52	25	serum	serum	NOUN
clinmedi-42	52	26	injections	injection	NOUN
clinmedi-42	52	27	in	in	ADP
clinmedi-42	52	28	the	the	DET
clinmedi-42	52	29	autologous	autologous	ADJ
clinmedi-42	52	30	serum	serum	NOUN
clinmedi-42	52	31	skin	skin	NOUN
clinmedi-42	52	32	test	test	NOUN
clinmedi-42	52	33	(	(	PUNCT
clinmedi-42	52	34	asst	asst	NOUN
clinmedi-42	52	35	)	)	PUNCT
clinmedi-42	53	1	[	[	X
clinmedi-42	53	2	9	9	NUM
clinmedi-42	53	3	]	]	PUNCT
clinmedi-42	53	4	.	.	PUNCT
clinmedi-42	54	1	approximately	approximately	ADV
clinmedi-42	54	2	50	50	NUM
clinmedi-42	54	3	%	%	NOUN
clinmedi-42	54	4	of	of	ADP
clinmedi-42	54	5	patients	patient	NOUN
clinmedi-42	54	6	with	with	ADP
clinmedi-42	54	7	idiopathic	idiopathic	ADJ
clinmedi-42	54	8	cu	cu	PROPN
clinmedi-42	54	9	have	have	VERB
clinmedi-42	54	10	igg	igg	PROPN
clinmedi-42	54	11	antibodies	antibody	NOUN
clinmedi-42	54	12	that	that	PRON
clinmedi-42	54	13	are	be	AUX
clinmedi-42	54	14	specific	specific	ADJ
clinmedi-42	54	15	for	for	ADP
clinmedi-42	54	16	the	the	DET
clinmedi-42	54	17	high	high	ADJ
clinmedi-42	54	18	affinity	affinity	NOUN
clinmedi-42	54	19	ige	ige	NOUN
clinmedi-42	54	20	receptor	receptor	NOUN
clinmedi-42	54	21	(	(	PUNCT
clinmedi-42	54	22	fcεri	fcεri	NOUN
clinmedi-42	54	23	)	)	PUNCT
clinmedi-42	55	1	[	[	X
clinmedi-42	55	2	10	10	NUM
clinmedi-42	55	3	,	,	PUNCT
clinmedi-42	55	4	11	11	NUM
clinmedi-42	55	5	]	]	PUNCT
clinmedi-42	55	6	.	.	PUNCT
clinmedi-42	56	1	these	these	DET
clinmedi-42	56	2	autoantibodies	autoantibody	NOUN
clinmedi-42	56	3	activate	activate	VERB
clinmedi-42	56	4	mast	mast	NOUN
clinmedi-42	56	5	cells	cell	NOUN
clinmedi-42	56	6	in	in	ADP
clinmedi-42	56	7	the	the	DET
clinmedi-42	56	8	skin	skin	NOUN
clinmedi-42	56	9	,	,	PUNCT
clinmedi-42	56	10	circulating	circulate	VERB
clinmedi-42	56	11	basophils	basophil	NOUN
clinmedi-42	56	12	,	,	PUNCT
clinmedi-42	56	13	and	and	CCONJ
clinmedi-42	56	14	the	the	DET
clinmedi-42	56	15	complement	complement	NOUN
clinmedi-42	56	16	system	system	NOUN
clinmedi-42	56	17	[	[	X
clinmedi-42	56	18	9	9	NUM
clinmedi-42	56	19	]	]	PUNCT
clinmedi-42	56	20	.	.	PUNCT
clinmedi-42	57	1	additional	additional	ADJ
clinmedi-42	57	2	immunological	immunological	ADJ
clinmedi-42	57	3	causes	cause	NOUN
clinmedi-42	57	4	in	in	ADP
clinmedi-42	57	5	cu	cu	PROPN
clinmedi-42	57	6	include	include	VERB
clinmedi-42	57	7	igg	igg	PROPN
clinmedi-42	57	8	antibodies	antibody	NOUN
clinmedi-42	57	9	directed	direct	VERB
clinmedi-42	57	10	against	against	ADP
clinmedi-42	57	11	ige	ige	PROPN
clinmedi-42	57	12	antibodies	antibody	NOUN
clinmedi-42	57	13	and	and	CCONJ
clinmedi-42	57	14	the	the	DET
clinmedi-42	57	15	low	low	ADJ
clinmedi-42	57	16	affinity	affinity	NOUN
clinmedi-42	57	17	ige	ige	NOUN
clinmedi-42	57	18	receptor	receptor	NOUN
clinmedi-42	57	19	(	(	PUNCT
clinmedi-42	57	20	fcεrii	fcεrii	PROPN
clinmedi-42	57	21	)	)	PUNCT
clinmedi-42	57	22	,	,	PUNCT
clinmedi-42	57	23	antiendothelial	antiendothelial	NOUN
clinmedi-42	57	24	antibodies	antibodie	VERB
clinmedi-42	57	25	,	,	PUNCT
clinmedi-42	57	26	and	and	CCONJ
clinmedi-42	57	27	complement	complement	VERB
clinmedi-42	57	28	c8	c8	PROPN
clinmedi-42	57	29	alpha	alpha	PROPN
clinmedi-42	57	30	-	-	PUNCT
clinmedi-42	57	31	gamma	gamma	PROPN
clinmedi-42	57	32	(	(	PUNCT
clinmedi-42	57	33	c8α	c8α	PROPN
clinmedi-42	57	34	-	-	PUNCT
clinmedi-42	57	35	γ	γ	NOUN
clinmedi-42	57	36	)	)	PUNCT
clinmedi-42	57	37	deficiency	deficiency	NOUN
clinmedi-42	58	1	[	[	X
clinmedi-42	58	2	12	12	NUM
clinmedi-42	58	3	]	]	PUNCT
clinmedi-42	58	4	.	.	PUNCT
clinmedi-42	59	1	our	our	PRON
clinmedi-42	59	2	patients	patient	NOUN
clinmedi-42	59	3	had	have	VERB
clinmedi-42	59	4	severe	severe	ADJ
clinmedi-42	59	5	and	and	CCONJ
clinmedi-42	59	6	persistent	persistent	ADJ
clinmedi-42	59	7	idiopathic	idiopathic	ADJ
clinmedi-42	59	8	cu	cu	PROPN
clinmedi-42	59	9	and	and	CCONJ
clinmedi-42	59	10	were	be	AUX
clinmedi-42	59	11	hardly	hardly	ADV
clinmedi-42	59	12	controlled	control	VERB
clinmedi-42	59	13	with	with	ADP
clinmedi-42	59	14	highdose	highdose	ADJ
clinmedi-42	59	15	corticosteroids	corticosteroid	NOUN
clinmedi-42	59	16	.	.	PUNCT
clinmedi-42	60	1	the	the	DET
clinmedi-42	60	2	latter	latter	ADJ
clinmedi-42	60	3	has	have	VERB
clinmedi-42	60	4	significant	significant	ADJ
clinmedi-42	60	5	long	long	ADJ
clinmedi-42	60	6	-	-	PUNCT
clinmedi-42	60	7	term	term	NOUN
clinmedi-42	60	8	side	side	NOUN
clinmedi-42	60	9	effects	effect	NOUN
clinmedi-42	60	10	viz	viz	PROPN
clinmedi-42	60	11	.	.	PUNCT
clinmedi-42	61	1	osteoporosis	osteoporosis	NOUN
clinmedi-42	61	2	,	,	PUNCT
clinmedi-42	61	3	hypertension	hypertension	NOUN
clinmedi-42	61	4	,	,	PUNCT
clinmedi-42	61	5	glucose	glucose	NOUN
clinmedi-42	61	6	intolerance	intolerance	NOUN
clinmedi-42	61	7	,	,	PUNCT
clinmedi-42	61	8	obesity	obesity	NOUN
clinmedi-42	61	9	,	,	PUNCT
clinmedi-42	61	10	stria	stria	NOUN
clinmedi-42	61	11	,	,	PUNCT
clinmedi-42	61	12	cushinoid	cushinoid	ADJ
clinmedi-42	61	13	appearance	appearance	NOUN
clinmedi-42	61	14	,	,	PUNCT
clinmedi-42	61	15	growth	growth	NOUN
clinmedi-42	61	16	retardation	retardation	NOUN
clinmedi-42	61	17	,	,	PUNCT
clinmedi-42	61	18	decreased	decrease	VERB
clinmedi-42	61	19	immunity	immunity	NOUN
clinmedi-42	61	20	,	,	PUNCT
clinmedi-42	61	21	poor	poor	ADJ
clinmedi-42	61	22	wound	wound	NOUN
clinmedi-42	61	23	healing	healing	NOUN
clinmedi-42	61	24	[	[	X
clinmedi-42	61	25	13	13	NUM
clinmedi-42	61	26	]	]	PUNCT
clinmedi-42	61	27	.	.	PUNCT
clinmedi-42	62	1	to	to	PART
clinmedi-42	62	2	avoid	avoid	VERB
clinmedi-42	62	3	corticosteroids	corticosteroid	NOUN
clinmedi-42	62	4	-	-	PUNCT
clinmedi-42	62	5	toxicity	toxicity	NOUN
clinmedi-42	62	6	,	,	PUNCT
clinmedi-42	62	7	multiple	multiple	ADJ
clinmedi-42	62	8	drugs	drug	NOUN
clinmedi-42	62	9	were	be	AUX
clinmedi-42	62	10	proposed	propose	VERB
clinmedi-42	62	11	for	for	ADP
clinmedi-42	62	12	such	such	ADJ
clinmedi-42	62	13	condition	condition	NOUN
clinmedi-42	62	14	viz	viz	PROPN
clinmedi-42	62	15	.	.	PUNCT
clinmedi-42	63	1	intravenous	intravenous	ADJ
clinmedi-42	63	2	immunoglobulin	immunoglobulin	NOUN
clinmedi-42	63	3	,	,	PUNCT
clinmedi-42	63	4	mycophenolate	mycophenolate	PROPN
clinmedi-42	63	5	mofetil	mofetil	PROPN
clinmedi-42	63	6	,	,	PUNCT
clinmedi-42	63	7	hydroxychloroquine	hydroxychloroquine	PROPN
clinmedi-42	63	8	,	,	PUNCT
clinmedi-42	63	9	and	and	CCONJ
clinmedi-42	63	10	tacrolimus	tacrolimus	X
clinmedi-42	64	1	[	[	X
clinmedi-42	64	2	1	1	NUM
clinmedi-42	64	3	]	]	PUNCT
clinmedi-42	64	4	.	.	PUNCT
clinmedi-42	65	1	all	all	DET
clinmedi-42	65	2	those	those	DET
clinmedi-42	65	3	drugs	drug	NOUN
clinmedi-42	65	4	were	be	AUX
clinmedi-42	65	5	tried	try	VERB
clinmedi-42	65	6	in	in	ADP
clinmedi-42	65	7	our	our	PRON
clinmedi-42	65	8	patients	patient	NOUN
clinmedi-42	65	9	and	and	CCONJ
clinmedi-42	65	10	,	,	PUNCT
clinmedi-42	65	11	had	have	AUX
clinmedi-42	65	12	failed	fail	VERB
clinmedi-42	65	13	to	to	PART
clinmedi-42	65	14	be	be	AUX
clinmedi-42	65	15	even	even	ADV
clinmedi-42	65	16	steroid	steroid	NOUN
clinmedi-42	65	17	-	-	PUNCT
clinmedi-42	65	18	sparing	spare	VERB
clinmedi-42	65	19	agents	agent	NOUN
clinmedi-42	65	20	.	.	PUNCT
clinmedi-42	66	1	since	since	SCONJ
clinmedi-42	66	2	cu	cu	PROPN
clinmedi-42	66	3	is	be	AUX
clinmedi-42	66	4	a	a	DET
clinmedi-42	66	5	disease	disease	NOUN
clinmedi-42	66	6	of	of	ADP
clinmedi-42	66	7	the	the	DET
clinmedi-42	66	8	mature	mature	ADJ
clinmedi-42	66	9	b	b	NOUN
clinmedi-42	66	10	producing	produce	VERB
clinmedi-42	66	11	excessive	excessive	ADJ
clinmedi-42	66	12	amounts	amount	NOUN
clinmedi-42	66	13	of	of	ADP
clinmedi-42	66	14	autoantibodies	autoantibody	NOUN
clinmedi-42	66	15	[	[	X
clinmedi-42	66	16	vida	vida	X
clinmedi-42	66	17	supra	supra	PROPN
clinmedi-42	66	18	]	]	PUNCT
clinmedi-42	66	19	,	,	PUNCT
clinmedi-42	66	20	we	we	PRON
clinmedi-42	66	21	elected	elect	VERB
clinmedi-42	66	22	to	to	PART
clinmedi-42	66	23	use	use	VERB
clinmedi-42	66	24	rituximab	rituximab	NOUN
clinmedi-42	66	25	in	in	ADP
clinmedi-42	66	26	such	such	ADJ
clinmedi-42	66	27	drug	drug	NOUN
clinmedi-42	66	28	-	-	PUNCT
clinmedi-42	66	29	refractory	refractory	NOUN
clinmedi-42	66	30	patients	patient	NOUN
clinmedi-42	66	31	.	.	PUNCT
clinmedi-42	67	1	rituximab	rituximab	NOUN
clinmedi-42	67	2	is	be	AUX
clinmedi-42	67	3	a	a	DET
clinmedi-42	67	4	murine	murine	ADJ
clinmedi-42	67	5	antibody	antibody	NOUN
clinmedi-42	67	6	that	that	PRON
clinmedi-42	67	7	destroys	destroy	VERB
clinmedi-42	67	8	both	both	CCONJ
clinmedi-42	67	9	normal	normal	ADJ
clinmedi-42	67	10	and	and	CCONJ
clinmedi-42	67	11	malignant	malignant	ADJ
clinmedi-42	67	12	b	b	PROPN
clinmedi-42	67	13	cells	cell	NOUN
clinmedi-42	68	1	b	b	PROPN
clinmedi-42	68	2	that	that	PRON
clinmedi-42	68	3	have	have	VERB
clinmedi-42	68	4	cd20	cd20	PROPN
clinmedi-42	68	5	on	on	ADP
clinmedi-42	68	6	their	their	PRON
clinmedi-42	68	7	surfaces	surface	NOUN
clinmedi-42	68	8	and	and	CCONJ
clinmedi-42	68	9	is	be	AUX
clinmedi-42	68	10	therefore	therefore	ADV
clinmedi-42	68	11	used	use	VERB
clinmedi-42	68	12	to	to	PART
clinmedi-42	68	13	treat	treat	VERB
clinmedi-42	68	14	diseases	disease	NOUN
clinmedi-42	68	15	which	which	PRON
clinmedi-42	68	16	are	be	AUX
clinmedi-42	68	17	characterized	characterize	VERB
clinmedi-42	68	18	by	by	ADP
clinmedi-42	68	19	having	have	VERB
clinmedi-42	68	20	too	too	ADV
clinmedi-42	68	21	many	many	ADJ
clinmedi-42	68	22	b	b	NOUN
clinmedi-42	68	23	cells	cell	NOUN
clinmedi-42	68	24	,	,	PUNCT
clinmedi-42	68	25	overactive	overactive	ADJ
clinmedi-42	68	26	b	b	NOUN
clinmedi-42	68	27	cells	cell	NOUN
clinmedi-42	68	28	,	,	PUNCT
clinmedi-42	68	29	or	or	CCONJ
clinmedi-42	68	30	dysfunctional	dysfunctional	ADJ
clinmedi-42	68	31	b	b	PROPN
clinmedi-42	68	32	cells	cell	NOUN
clinmedi-42	68	33	.	.	PUNCT
clinmedi-42	69	1	the	the	DET
clinmedi-42	69	2	following	following	ADJ
clinmedi-42	69	3	effects	effect	NOUN
clinmedi-42	69	4	have	have	AUX
clinmedi-42	69	5	been	be	AUX
clinmedi-42	69	6	found	find	VERB
clinmedi-42	69	7	:	:	PUNCT
clinmedi-42	69	8	(	(	PUNCT
clinmedi-42	69	9	a	a	X
clinmedi-42	69	10	)	)	PUNCT
clinmedi-42	69	11	the	the	DET
clinmedi-42	69	12	fc	fc	PROPN
clinmedi-42	69	13	portion	portion	NOUN
clinmedi-42	69	14	of	of	ADP
clinmedi-42	69	15	rituximab	rituximab	NOUN
clinmedi-42	69	16	mediates	mediate	NOUN
clinmedi-42	69	17	antibody	antibody	NOUN
clinmedi-42	69	18	-	-	PUNCT
clinmedi-42	69	19	dependent	dependent	ADJ
clinmedi-42	69	20	cellular	cellular	ADJ
clinmedi-42	69	21	cytotoxicity	cytotoxicity	NOUN
clinmedi-42	69	22	(	(	PUNCT
clinmedi-42	69	23	adcc	adcc	NOUN
clinmedi-42	69	24	)	)	PUNCT
clinmedi-42	69	25	and	and	CCONJ
clinmedi-42	69	26	rituximab	rituximab	NOUN
clinmedi-42	69	27	treatment	treatment	NOUN
clinmedi-42	69	28	for	for	ADP
clinmedi-42	69	29	chronic	chronic	ADJ
clinmedi-42	69	30	idiopathic	idiopathic	ADJ
clinmedi-42	69	31	urticaria	urticaria	NOUN
clinmedi-42	69	32	with	with	ADP
clinmedi-42	69	33	recurrent	recurrent	ADJ
clinmedi-42	69	34	angioedema	angioedema	NOUN
clinmedi-42	69	35	clinical	clinical	ADJ
clinmedi-42	69	36	medicine	medicine	NOUN
clinmedi-42	69	37	insights	insight	NOUN
clinmedi-42	69	38	page	page	VERB
clinmedi-42	69	39	8	8	NUM
clinmedi-42	69	40	complement	complement	NOUN
clinmedi-42	69	41	-	-	PUNCT
clinmedi-42	69	42	dependent	dependent	ADJ
clinmedi-42	69	43	cytotoxicity	cytotoxicity	NOUN
clinmedi-42	69	44	(	(	PUNCT
clinmedi-42	69	45	cdc	cdc	PROPN
clinmedi-42	69	46	.	.	PUNCT
clinmedi-42	70	1	(	(	PUNCT
clinmedi-42	70	2	b	b	X
clinmedi-42	70	3	)	)	PUNCT
clinmedi-42	70	4	rituximab	rituximab	NOUN
clinmedi-42	70	5	has	have	VERB
clinmedi-42	70	6	a	a	DET
clinmedi-42	70	7	general	general	ADJ
clinmedi-42	70	8	regulatory	regulatory	ADJ
clinmedi-42	70	9	effect	effect	NOUN
clinmedi-42	70	10	on	on	ADP
clinmedi-42	70	11	the	the	DET
clinmedi-42	70	12	cell	cell	NOUN
clinmedi-42	70	13	cycle	cycle	NOUN
clinmedi-42	70	14	.	.	PUNCT
clinmedi-42	71	1	(	(	PUNCT
clinmedi-42	71	2	c	c	X
clinmedi-42	71	3	)	)	PUNCT
clinmedi-42	71	4	it	it	PRON
clinmedi-42	71	5	increases	increase	VERB
clinmedi-42	71	6	mhc	mhc	PROPN
clinmedi-42	71	7	ii	ii	PROPN
clinmedi-42	71	8	and	and	CCONJ
clinmedi-42	71	9	adhesion	adhesion	NOUN
clinmedi-42	71	10	molecules	molecule	NOUN
clinmedi-42	71	11	lfa-1	lfa-1	NUM
clinmedi-42	71	12	and	and	CCONJ
clinmedi-42	71	13	lfa-3	lfa-3	PUNCT
clinmedi-42	71	14	(	(	PUNCT
clinmedi-42	71	15	lymphocyte	lymphocyte	ADJ
clinmedi-42	71	16	function	function	NOUN
clinmedi-42	71	17	-	-	PUNCT
clinmedi-42	71	18	associated	associate	VERB
clinmedi-42	71	19	antigen	antigen	NOUN
clinmedi-42	71	20	)	)	PUNCT
clinmedi-42	71	21	.	.	PUNCT
clinmedi-42	72	1	(	(	PUNCT
clinmedi-42	72	2	d	d	X
clinmedi-42	72	3	)	)	PUNCT
clinmedi-42	72	4	it	it	PRON
clinmedi-42	72	5	elicits	elicit	VERB
clinmedi-42	72	6	shedding	shed	VERB
clinmedi-42	72	7	of	of	ADP
clinmedi-42	72	8	cd23	cd23	PROPN
clinmedi-42	72	9	.	.	PUNCT
clinmedi-42	73	1	(	(	PUNCT
clinmedi-42	73	2	e	e	X
clinmedi-42	73	3	)	)	PUNCT
clinmedi-42	73	4	it	it	PRON
clinmedi-42	73	5	down	down	ADV
clinmedi-42	73	6	regulates	regulate	VERB
clinmedi-42	73	7	the	the	DET
clinmedi-42	73	8	b	b	PROPN
clinmedi-42	73	9	cell	cell	NOUN
clinmedi-42	73	10	receptors	receptor	NOUN
clinmedi-42	73	11	(	(	PUNCT
clinmedi-42	73	12	f	f	X
clinmedi-42	73	13	)	)	PUNCT
clinmedi-42	73	14	it	it	PRON
clinmedi-42	73	15	induces	induce	VERB
clinmedi-42	73	16	apoptosis	apoptosis	NOUN
clinmedi-42	73	17	of	of	ADP
clinmedi-42	73	18	the	the	DET
clinmedi-42	73	19	cd20	cd20	PROPN
clinmedi-42	73	20	+	+	NUM
clinmedi-42	73	21	cells	cell	NOUN
clinmedi-42	73	22	[	[	X
clinmedi-42	73	23	14	14	NUM
clinmedi-42	73	24	]	]	PUNCT
clinmedi-42	73	25	.	.	PUNCT
clinmedi-42	74	1	the	the	DET
clinmedi-42	74	2	latter	latter	ADJ
clinmedi-42	74	3	may	may	AUX
clinmedi-42	74	4	be	be	AUX
clinmedi-42	74	5	the	the	DET
clinmedi-42	74	6	basis	basis	NOUN
clinmedi-42	74	7	of	of	ADP
clinmedi-42	74	8	maintenance	maintenance	NOUN
clinmedi-42	74	9	of	of	ADP
clinmedi-42	74	10	long	long	ADJ
clinmedi-42	74	11	-	-	PUNCT
clinmedi-42	74	12	term	term	NOUN
clinmedi-42	74	13	remission	remission	NOUN
clinmedi-42	74	14	via	via	ADP
clinmedi-42	74	15	generation	generation	NOUN
clinmedi-42	74	16	of	of	ADP
clinmedi-42	74	17	new	new	ADJ
clinmedi-42	74	18	cells	cell	NOUN
clinmedi-42	74	19	without	without	ADP
clinmedi-42	74	20	memory	memory	NOUN
clinmedi-42	74	21	ones	one	NOUN
clinmedi-42	74	22	[	[	X
clinmedi-42	74	23	15	15	NUM
clinmedi-42	74	24	]	]	PUNCT
clinmedi-42	74	25	.	.	PUNCT
clinmedi-42	75	1	in	in	ADP
clinmedi-42	75	2	conclusion	conclusion	NOUN
clinmedi-42	75	3	;	;	PUNCT
clinmedi-42	75	4	our	our	PRON
clinmedi-42	75	5	results	result	NOUN
clinmedi-42	75	6	are	be	AUX
clinmedi-42	75	7	promising	promise	VERB
clinmedi-42	75	8	for	for	ADP
clinmedi-42	75	9	a	a	DET
clinmedi-42	75	10	new	new	ADJ
clinmedi-42	75	11	hope	hope	NOUN
clinmedi-42	75	12	in	in	ADP
clinmedi-42	75	13	treatment	treatment	NOUN
clinmedi-42	75	14	of	of	ADP
clinmedi-42	75	15	drug	drug	NOUN
clinmedi-42	75	16	-	-	PUNCT
clinmedi-42	75	17	refractory	refractory	NOUN
clinmedi-42	75	18	cu	cu	PROPN
clinmedi-42	75	19	with	with	ADP
clinmedi-42	75	20	rituximabtreatment	rituximabtreatment	NOUN
clinmedi-42	75	21	.	.	PUNCT
clinmedi-42	76	1	the	the	DET
clinmedi-42	76	2	latter	latter	ADJ
clinmedi-42	76	3	is	be	AUX
clinmedi-42	76	4	safe	safe	ADJ
clinmedi-42	76	5	and	and	CCONJ
clinmedi-42	76	6	is	be	AUX
clinmedi-42	76	7	able	able	ADJ
clinmedi-42	76	8	to	to	PART
clinmedi-42	76	9	produce	produce	VERB
clinmedi-42	76	10	a	a	DET
clinmedi-42	76	11	long	long	ADV
clinmedi-42	76	12	-	-	PUNCT
clinmedi-42	76	13	lasting	last	VERB
clinmedi-42	76	14	remission	remission	NOUN
clinmedi-42	76	15	of	of	ADP
clinmedi-42	76	16	a	a	DET
clinmedi-42	76	17	disabling	disable	VERB
clinmedi-42	76	18	disease	disease	NOUN
clinmedi-42	76	19	.	.	PUNCT
clinmedi-42	77	1	references	reference	NOUN
clinmedi-42	77	2	:	:	PUNCT
clinmedi-42	77	3	1bernstein	1bernstein	NUM
clinmedi-42	77	4	ja	ja	PROPN
clinmedi-42	77	5	,	,	PUNCT
clinmedi-42	77	6	lang	lang	PROPN
clinmedi-42	77	7	dm	dm	PROPN
clinmedi-42	77	8	,	,	PUNCT
clinmedi-42	77	9	md	md	PROPN
clinmedi-42	77	10	,	,	PUNCT
clinmedi-42	77	11	khan	khan	PROPN
clinmedi-42	77	12	da	da	PROPN
clinmedi-42	77	13	.	.	PUNCT
clinmedi-42	78	1	the	the	DET
clinmedi-42	78	2	diagnosis	diagnosis	NOUN
clinmedi-42	78	3	and	and	CCONJ
clinmedi-42	78	4	management	management	NOUN
clinmedi-42	78	5	of	of	ADP
clinmedi-42	78	6	acute	acute	ADJ
clinmedi-42	78	7	and	and	CCONJ
clinmedi-42	78	8	chronic	chronic	ADJ
clinmedi-42	78	9	urticaria	urticaria	NOUN
clinmedi-42	78	10	:	:	PUNCT
clinmedi-42	78	11	2014	2014	NUM
clinmedi-42	78	12	update	update	NOUN
clinmedi-42	78	13	.	.	PUNCT
clinmedi-42	79	1	j	j	PROPN
clinmedi-42	79	2	allergy	allergy	PROPN
clinmedi-42	79	3	clin	clin	PROPN
clinmedi-42	79	4	immunol	immunol	PROPN
clinmedi-42	79	5	2014	2014	NUM
clinmedi-42	79	6	;	;	PUNCT
clinmedi-42	79	7	133	133	NUM
clinmedi-42	79	8	:	:	SYM
clinmedi-42	79	9	1271	1271	NUM
clinmedi-42	79	10	-	-	SYM
clinmedi-42	79	11	1277	1277	NUM
clinmedi-42	79	12	.	.	PUNCT
clinmedi-42	80	1	2toubi	2toubi	NUM
clinmedi-42	80	2	e	e	NOUN
clinmedi-42	80	3	,	,	PUNCT
clinmedi-42	80	4	kessel	kessel	PROPN
clinmedi-42	80	5	a	a	PROPN
clinmedi-42	80	6	,	,	PUNCT
clinmedi-42	80	7	avshovich	avshovich	PROPN
clinmedi-42	80	8	n	n	CCONJ
clinmedi-42	80	9	,	,	PUNCT
clinmedi-42	80	10	et	et	PROPN
clinmedi-42	80	11	al	al	PROPN
clinmedi-42	80	12	.	.	PROPN
clinmedi-42	81	1	clinical	clinical	ADJ
clinmedi-42	81	2	and	and	CCONJ
clinmedi-42	81	3	laboratory	laboratory	NOUN
clinmedi-42	81	4	parameters	parameter	NOUN
clinmedi-42	81	5	in	in	ADP
clinmedi-42	81	6	predicting	predict	VERB
clinmedi-42	81	7	chronic	chronic	ADJ
clinmedi-42	81	8	urticaria	urticaria	NOUN
clinmedi-42	81	9	duration	duration	NOUN
clinmedi-42	81	10	:	:	PUNCT
clinmedi-42	81	11	a	a	DET
clinmedi-42	81	12	prospective	prospective	ADJ
clinmedi-42	81	13	study	study	NOUN
clinmedi-42	81	14	of	of	ADP
clinmedi-42	81	15	139	139	NUM
clinmedi-42	81	16	patients	patient	NOUN
clinmedi-42	81	17	.	.	PUNCT
clinmedi-42	82	1	allergy	allergy	NOUN
clinmedi-42	82	2	.	.	PUNCT
clinmedi-42	83	1	2004	2004	NUM
clinmedi-42	83	2	aug;59(8):869	aug;59(8):869	PROPN
clinmedi-42	83	3	-	-	PUNCT
clinmedi-42	83	4	873	873	NUM
clinmedi-42	83	5	.	.	PUNCT
clinmedi-42	84	1	3o'donnell	3o'donnell	PROPN
clinmedi-42	84	2	bf	bf	NOUN
clinmedi-42	84	3	,	,	PUNCT
clinmedi-42	84	4	lawlor	lawlor	PROPN
clinmedi-42	84	5	f	f	PROPN
clinmedi-42	84	6	,	,	PUNCT
clinmedi-42	84	7	simpson	simpson	PROPN
clinmedi-42	84	8	j	j	PROPN
clinmedi-42	84	9	,	,	PUNCT
clinmedi-42	84	10	morgan	morgan	PROPN
clinmedi-42	84	11	m	m	PROPN
clinmedi-42	84	12	,	,	PUNCT
clinmedi-42	84	13	greaves	greave	VERB
clinmedi-42	84	14	mw	mw	VERB
clinmedi-42	84	15	.	.	PUNCT
clinmedi-42	85	1	the	the	DET
clinmedi-42	85	2	impact	impact	NOUN
clinmedi-42	85	3	of	of	ADP
clinmedi-42	85	4	chronic	chronic	ADJ
clinmedi-42	85	5	urticaria	urticaria	NOUN
clinmedi-42	85	6	on	on	ADP
clinmedi-42	85	7	quality	quality	NOUN
clinmedi-42	85	8	of	of	ADP
clinmedi-42	85	9	life	life	NOUN
clinmedi-42	85	10	.	.	PUNCT
clinmedi-42	86	1	br	br	PROPN
clinmedi-42	86	2	j	j	PROPN
clinmedi-42	86	3	dermatol	dermatol	NOUN
clinmedi-42	86	4	.	.	PUNCT
clinmedi-42	87	1	1997;136:197–201	1997;136:197–201	NUM
clinmedi-42	87	2	.	.	PUNCT
clinmedi-42	88	1	4hellgren	4hellgren	NUM
clinmedi-42	88	2	l.	l.	NOUN
clinmedi-42	88	3	the	the	DET
clinmedi-42	88	4	prevalence	prevalence	NOUN
clinmedi-42	88	5	of	of	ADP
clinmedi-42	88	6	urtecaria	urtecaria	NOUN
clinmedi-42	88	7	in	in	ADP
clinmedi-42	88	8	the	the	DET
clinmedi-42	88	9	total	total	ADJ
clinmedi-42	88	10	population	population	NOUN
clinmedi-42	88	11	.	.	PUNCT
clinmedi-42	89	1	acta	acta	PROPN
clinmedi-42	89	2	allergol	allergol	PROPN
clinmedi-42	89	3	1972	1972	NUM
clinmedi-42	89	4	;	;	PUNCT
clinmedi-42	89	5	27	27	NUM
clinmedi-42	89	6	:	:	SYM
clinmedi-42	89	7	236	236	NUM
clinmedi-42	89	8	-	-	SYM
clinmedi-42	89	9	240	240	NUM
clinmedi-42	89	10	.	.	PUNCT
clinmedi-42	90	1	5kaplan	5kaplan	NUM
clinmedi-42	90	2	ap	ap	PROPN
clinmedi-42	90	3	,	,	PUNCT
clinmedi-42	90	4	greaves	greave	VERB
clinmedi-42	90	5	m.	m.	NOUN
clinmedi-42	90	6	pathogenesis	pathogenesis	NOUN
clinmedi-42	90	7	of	of	ADP
clinmedi-42	90	8	chronic	chronic	ADJ
clinmedi-42	90	9	urticaria	urticaria	NOUN
clinmedi-42	90	10	.	.	PUNCT
clinmedi-42	91	1	clin	clin	PROPN
clinmedi-42	91	2	exp	exp	NOUN
clinmedi-42	91	3	allergy	allergy	PROPN
clinmedi-42	91	4	.	.	PUNCT
clinmedi-42	92	1	2009;39:777–87	2009;39:777–87	NUM
clinmedi-42	92	2	.	.	PUNCT
clinmedi-42	93	1	6dice	6dice	NUM
clinmedi-42	93	2	jp	jp	NOUN
clinmedi-42	93	3	.	.	PUNCT
clinmedi-42	94	1	physical	physical	ADJ
clinmedi-42	94	2	urticaria	urticaria	NOUN
clinmedi-42	94	3	.	.	PUNCT
clinmedi-42	95	1	immunol	immunol	NOUN
clinmedi-42	95	2	allergy	allergy	PROPN
clinmedi-42	95	3	clin	clin	PROPN
clinmedi-42	95	4	north	north	PROPN
clinmedi-42	95	5	am	am	PROPN
clinmedi-42	95	6	.	.	PUNCT
clinmedi-42	96	1	2004	2004	NUM
clinmedi-42	96	2	may	may	AUX
clinmedi-42	96	3	;	;	PUNCT
clinmedi-42	96	4	24(2):225	24(2):225	NUM
clinmedi-42	96	5	-	-	SYM
clinmedi-42	96	6	46	46	NUM
clinmedi-42	96	7	.	.	PUNCT
clinmedi-42	97	1	7chang	7chang	NUM
clinmedi-42	97	2	s	s	PROPN
clinmedi-42	97	3	,	,	PUNCT
clinmedi-42	97	4	carr	carr	PROPN
clinmedi-42	97	5	w.	w.	PROPN
clinmedi-42	97	6	urticarial	urticarial	PROPN
clinmedi-42	97	7	vasculitis	vasculitis	PROPN
clinmedi-42	97	8	.	.	PUNCT
clinmedi-42	98	1	allergy	allergy	PROPN
clinmedi-42	98	2	asthma	asthma	PROPN
clinmedi-42	98	3	proc	proc	PROPN
clinmedi-42	98	4	.	.	PUNCT
clinmedi-42	99	1	2007	2007	NUM
clinmedi-42	99	2	jan	jan	PROPN
clinmedi-42	99	3	-	-	PUNCT
clinmedi-42	99	4	feb	feb	NOUN
clinmedi-42	99	5	;	;	PUNCT
clinmedi-42	99	6	28(1):97	28(1):97	NUM
clinmedi-42	99	7	-	-	SYM
clinmedi-42	99	8	100	100	NUM
clinmedi-42	99	9	.	.	PUNCT
clinmedi-42	100	1	8champion	8champion	NUM
clinmedi-42	100	2	rh	rh	PROPN
clinmedi-42	100	3	,	,	PUNCT
clinmedi-42	100	4	roberts	roberts	PROPN
clinmedi-42	100	5	so	so	ADV
clinmedi-42	100	6	,	,	PUNCT
clinmedi-42	100	7	carpenter	carpenter	PROPN
clinmedi-42	100	8	rg	rg	PROPN
clinmedi-42	100	9	,	,	PUNCT
clinmedi-42	100	10	et	et	PROPN
clinmedi-42	100	11	al	al	PROPN
clinmedi-42	100	12	.	.	PROPN
clinmedi-42	100	13	urticaria	urticaria	PROPN
clinmedi-42	100	14	and	and	CCONJ
clinmedi-42	100	15	angio	angio	NOUN
clinmedi-42	100	16	-	-	NOUN
clinmedi-42	100	17	oedema	oedema	NOUN
clinmedi-42	100	18	.	.	PUNCT
clinmedi-42	101	1	a	a	DET
clinmedi-42	101	2	review	review	NOUN
clinmedi-42	101	3	of	of	ADP
clinmedi-42	101	4	554	554	NUM
clinmedi-42	101	5	patients	patient	NOUN
clinmedi-42	101	6	.	.	PUNCT
clinmedi-42	102	1	br	br	PROPN
clinmedi-42	102	2	j	j	PROPN
clinmedi-42	102	3	dermatol	dermatol	NOUN
clinmedi-42	102	4	.	.	PUNCT
clinmedi-42	102	5	1969	1969	NUM
clinmedi-42	102	6	aug;81(8):588	aug;81(8):588	X
clinmedi-42	102	7	-	-	PUNCT
clinmedi-42	102	8	597	597	NUM
clinmedi-42	102	9	.	.	PUNCT
clinmedi-42	103	1	9sabroe	9sabroe	NUM
clinmedi-42	103	2	ra	ra	PROPN
clinmedi-42	103	3	,	,	PUNCT
clinmedi-42	103	4	grattan	grattan	PROPN
clinmedi-42	103	5	ce	ce	PROPN
clinmedi-42	103	6	,	,	PUNCT
clinmedi-42	103	7	francis	francis	PROPN
clinmedi-42	103	8	dm	dm	PROPN
clinmedi-42	103	9	,	,	PUNCT
clinmedi-42	103	10	et	et	PROPN
clinmedi-42	103	11	al	al	PROPN
clinmedi-42	103	12	.	.	PUNCT
clinmedi-42	104	1	the	the	DET
clinmedi-42	104	2	autologous	autologous	ADJ
clinmedi-42	104	3	serum	serum	NOUN
clinmedi-42	104	4	skin	skin	NOUN
clinmedi-42	104	5	test	test	NOUN
clinmedi-42	104	6	:	:	PUNCT
clinmedi-42	104	7	a	a	DET
clinmedi-42	104	8	screening	screening	NOUN
clinmedi-42	104	9	test	test	NOUN
clinmedi-42	104	10	for	for	ADP
clinmedi-42	104	11	autoantibodies	autoantibody	NOUN
clinmedi-42	104	12	in	in	ADP
clinmedi-42	104	13	chronic	chronic	ADJ
clinmedi-42	104	14	idiopathic	idiopathic	ADJ
clinmedi-42	104	15	urticaria	urticaria	NOUN
clinmedi-42	104	16	.	.	PUNCT
clinmedi-42	105	1	br	br	PROPN
clinmedi-42	105	2	j	j	PROPN
clinmedi-42	105	3	dermatol	dermatol	NOUN
clinmedi-42	105	4	.	.	PUNCT
clinmedi-42	106	1	1999	1999	NUM
clinmedi-42	106	2	mar;140(3):446	mar;140(3):446	NOUN
clinmedi-42	106	3	-	-	VERB
clinmedi-42	106	4	52	52	NUM
clinmedi-42	106	5	.	.	PUNCT
clinmedi-42	106	6	10kaplan	10kaplan	NUM
clinmedi-42	106	7	ap	ap	PROPN
clinmedi-42	106	8	.	.	PUNCT
clinmedi-42	107	1	chronic	chronic	ADJ
clinmedi-42	107	2	urticaria	urticaria	NOUN
clinmedi-42	107	3	:	:	PUNCT
clinmedi-42	107	4	pathogenesis	pathogenesis	NOUN
clinmedi-42	107	5	and	and	CCONJ
clinmedi-42	107	6	treatment	treatment	NOUN
clinmedi-42	107	7	.	.	PUNCT
clinmedi-42	108	1	j	j	PROPN
clinmedi-42	108	2	allergy	allergy	PROPN
clinmedi-42	108	3	clin	clin	PROPN
clinmedi-42	108	4	immunol	immunol	PROPN
clinmedi-42	108	5	.	.	PUNCT
clinmedi-42	109	1	2004	2004	NUM
clinmedi-42	109	2	sep;114(3):465	sep;114(3):465	NOUN
clinmedi-42	109	3	-	-	PUNCT
clinmedi-42	109	4	474	474	NUM
clinmedi-42	109	5	.	.	PUNCT
clinmedi-42	110	1	11hide	11hide	NUM
clinmedi-42	110	2	m	m	PROPN
clinmedi-42	110	3	,	,	PUNCT
clinmedi-42	110	4	francis	francis	PROPN
clinmedi-42	110	5	dm	dm	PROPN
clinmedi-42	110	6	,	,	PUNCT
clinmedi-42	110	7	grattan	grattan	PROPN
clinmedi-42	110	8	ce	ce	PROPN
clinmedi-42	110	9	,	,	PUNCT
clinmedi-42	110	10	et	et	PROPN
clinmedi-42	110	11	al	al	PROPN
clinmedi-42	110	12	.	.	PUNCT
clinmedi-42	110	13	autoantibodies	autoantibody	NOUN
clinmedi-42	110	14	against	against	ADP
clinmedi-42	110	15	the	the	DET
clinmedi-42	110	16	high	high	ADJ
clinmedi-42	110	17	-	-	PUNCT
clinmedi-42	110	18	affinity	affinity	NOUN
clinmedi-42	110	19	ige	ige	NOUN
clinmedi-42	110	20	receptor	receptor	NOUN
clinmedi-42	110	21	as	as	ADP
clinmedi-42	110	22	a	a	DET
clinmedi-42	110	23	cause	cause	NOUN
clinmedi-42	110	24	of	of	ADP
clinmedi-42	110	25	histamine	histamine	NOUN
clinmedi-42	110	26	release	release	NOUN
clinmedi-42	110	27	in	in	ADP
clinmedi-42	110	28	chronic	chronic	ADJ
clinmedi-42	110	29	urticaria	urticaria	NOUN
clinmedi-42	110	30	.	.	PUNCT
clinmedi-42	111	1	n	n	PROPN
clinmedi-42	111	2	engl	engl	PROPN
clinmedi-42	111	3	j	j	PROPN
clinmedi-42	111	4	med	med	PROPN
clinmedi-42	111	5	.	.	PUNCT
clinmedi-42	112	1	1993	1993	NUM
clinmedi-42	112	2	jun	jun	PROPN
clinmedi-42	112	3	3;328(22):1599	3;328(22):1599	NUM
clinmedi-42	112	4	-	-	PUNCT
clinmedi-42	112	5	1604	1604	NUM
clinmedi-42	112	6	.	.	PUNCT
clinmedi-42	113	1	12puccetti	12puccetti	NUM
clinmedi-42	114	1	a	a	DET
clinmedi-42	114	2	,	,	PUNCT
clinmedi-42	114	3	bason	bason	ADJ
clinmedi-42	114	4	c	c	NOUN
clinmedi-42	114	5	,	,	PUNCT
clinmedi-42	114	6	simeoni	simeoni	VERB
clinmedi-42	114	7	s	s	PROPN
clinmedi-42	114	8	,	,	PUNCT
clinmedi-42	114	9	et	et	PROPN
clinmedi-42	114	10	al	al	PROPN
clinmedi-42	114	11	.	.	PUNCT
clinmedi-42	115	1	in	in	ADP
clinmedi-42	115	2	chronic	chronic	ADJ
clinmedi-42	115	3	idiopathic	idiopathic	ADJ
clinmedi-42	115	4	urticaria	urticaria	NOUN
clinmedi-42	115	5	autoantibodies	autoantibody	NOUN
clinmedi-42	115	6	against	against	ADP
clinmedi-42	115	7	fc	fc	PROPN
clinmedi-42	115	8	epsilonrii	epsilonrii	PROPN
clinmedi-42	115	9	/	/	SYM
clinmedi-42	115	10	cd23	cd23	PROPN
clinmedi-42	115	11	induce	induce	VERB
clinmedi-42	115	12	histamine	histamine	NOUN
clinmedi-42	115	13	release	release	NOUN
clinmedi-42	115	14	via	via	ADP
clinmedi-42	115	15	eosinophil	eosinophil	ADJ
clinmedi-42	115	16	activation	activation	NOUN
clinmedi-42	115	17	.	.	PUNCT
clinmedi-42	116	1	clin	clin	PROPN
clinmedi-42	116	2	exp	exp	PROPN
clinmedi-42	116	3	allergy	allergy	PROPN
clinmedi-42	116	4	.	.	PUNCT
clinmedi-42	117	1	2005	2005	NUM
clinmedi-42	117	2	dec;35(12):1599	dec;35(12):1599	X
clinmedi-42	117	3	-	-	PUNCT
clinmedi-42	117	4	1607	1607	NUM
clinmedi-42	117	5	.	.	PUNCT
clinmedi-42	118	1	13bosch	13bosch	PUNCT
clinmedi-42	119	1	x	x	X
clinmedi-42	119	2	,	,	PUNCT
clinmedi-42	119	3	ramos	ramo	NOUN
clinmedi-42	119	4	-	-	NOUN
clinmedi-42	119	5	casals	casal	NOUN
clinmedi-42	119	6	m	m	PROPN
clinmedi-42	119	7	,	,	PUNCT
clinmedi-42	119	8	khamashta	khamashta	PROPN
clinmedi-42	119	9	ma	ma	PROPN
clinmedi-42	119	10	.	.	PROPN
clinmedi-42	120	1	drugs	drug	NOUN
clinmedi-42	120	2	targeting	target	VERB
clinmedi-42	120	3	b	b	NOUN
clinmedi-42	120	4	-	-	NOUN
clinmedi-42	120	5	cells	cell	NOUN
clinmedi-42	120	6	in	in	ADP
clinmedi-42	120	7	autoimmune	autoimmune	ADJ
clinmedi-42	120	8	diseases	disease	NOUN
clinmedi-42	120	9	.	.	PUNCT
clinmedi-42	121	1	springer	springer	NOUN
clinmedi-42	121	2	science	science	PROPN
clinmedi-42	121	3	&	&	CCONJ
clinmedi-42	121	4	business	business	NOUN
clinmedi-42	121	5	media	medium	NOUN
clinmedi-42	121	6	;	;	PUNCT
clinmedi-42	121	7	2013	2013	NUM
clinmedi-42	121	8	:	:	PUNCT
clinmedi-42	122	1	1	1	NUM
clinmedi-42	122	2	-	-	SYM
clinmedi-42	122	3	4	4	NUM
clinmedi-42	122	4	.	.	PUNCT
clinmedi-42	122	5	14shaw	14shaw	NUM
clinmedi-42	122	6	t	t	PROPN
clinmedi-42	122	7	,	,	PUNCT
clinmedi-42	122	8	quan	quan	PROPN
clinmedi-42	122	9	j	j	PROPN
clinmedi-42	122	10	,	,	PUNCT
clinmedi-42	122	11	totoritis	totoritis	NOUN
clinmedi-42	122	12	m.	m.	NOUN
clinmedi-42	122	13	b	b	NOUN
clinmedi-42	122	14	cell	cell	NOUN
clinmedi-42	122	15	therapy	therapy	NOUN
clinmedi-42	122	16	for	for	ADP
clinmedi-42	122	17	rheumatoid	rheumatoid	NOUN
clinmedi-42	122	18	arthritis	arthritis	NOUN
clinmedi-42	122	19	:	:	PUNCT
clinmedi-42	122	20	the	the	DET
clinmedi-42	122	21	rituximab	rituximab	NOUN
clinmedi-42	122	22	(	(	PUNCT
clinmedi-42	122	23	anti	anti	ADJ
clinmedi-42	122	24	-	-	ADJ
clinmedi-42	122	25	cd20	cd20	ADJ
clinmedi-42	122	26	)	)	PUNCT
clinmedi-42	122	27	experience	experience	NOUN
clinmedi-42	122	28	.	.	PUNCT
clinmedi-42	123	1	ann	ann	PROPN
clinmedi-42	123	2	rheum	rheum	PROPN
clinmedi-42	123	3	dis	dis	PROPN
clinmedi-42	123	4	2003	2003	NUM
clinmedi-42	123	5	;	;	PUNCT
clinmedi-42	123	6	62	62	NUM
clinmedi-42	123	7	(	(	PUNCT
clinmedi-42	123	8	suppl	suppl	NOUN
clinmedi-42	123	9	2	2	NUM
clinmedi-42	123	10	):	):	PUNCT
clinmedi-42	123	11	ii55	ii55	PROPN
clinmedi-42	123	12	-	-	PUNCT
clinmedi-42	123	13	ii59	ii59	PROPN
clinmedi-42	123	14	.	.	PUNCT